|
Glossary of Chemical Names Used in the Enzyme List
(Click the  icon to search ChemSpider for the primary term.)
| 5a,11a-dehydrotetracycline | = 12-dehydrotetracycline |
| = (4S,4aS,6S,12aS)-4-dimethylamino-3,6,10,12a-tetrahydroxy-6-methyl-1,11,12-trioxo-1,4,4a,5,6,11,12,12a-octahydrotetracene-2-carboxamide |
| D-abequose | = 3,6-deoxy-D-xylo-hexose |
| = 3,6-deoxy-D-galactose |
| = 3-deoxy-D-fucose |
| abieta-7,13-dien-18-al | = (1R,4aR,4bR,10aR)-7-isopropyl-1,4a-dimethyl-1,2,3,4,4a,4b,5,6,10,10a-decahydrophenanthrene-1-carbaldehyde |
| abieta-7,13-dien-18-oate | = (1R,4aR,4bR,10aR)-7-isopropyl-1,4a-dimethyl-1,2,3,4,4a,4b,5,6,10,10a-decahydrophenanthrene-1-carboxylate |
| abieta-7,13-dien-18-ol | = ((1R,4aR,4bR,10aR)-7-isopropyl-1,4a-dimethyl-1,2,3,4,4a,4b,5,6,10,10a-decahydrophenanthren-1-yl)methanol |
| abieta-7,13-diene | = (4aS,4bR,10aS)-7-isopropyl-1,1,4a-trimethyl-1,2,3,4,4a,4b,5,6,10,10a-decahydrophenanthrene |
| acacetin | = 4′-methoxy-5,7-dihydroxyflavone |
| acarbose | = 4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino}-α-D-glucopyranosyl-(1→4)-α-D-glucopyranosyl-(1→4)-β-D-glucopyranose |
| aceneuramate | = (4S,5R,6R,7S,8R)-5-acetamido-4,6,7,8,9-pentahydroxy-2-oxononanoate |
| acetochlor | = N-(ethoxymethyl)-2-chloro-N-(2-ethyl,6-methylphenyl)acetamide |
| 3-O-acetylpapaveroxine | = 6-{(S)-acetoxy[(5R)-4-methoxy-6-methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-5-yl]methyl}-2,3-dimethoxybenzaldehyde |
| acharan | = [GlcNAc-α-(1→4)-IdoA-α-(1→4)]n |
| acireductone | = 1,2-dihydroxy-5-(methylsulfanyl)pent-1-en-3-one |
| aclacinomycin A | = 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R,6S)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]naphthacene-1-carboxylic acid methyl ester |
| aclacinomycin A | = 2-ethyl-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R,6S)-6-methyl-5-oxotetrahydro-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-1,2,3,4,6,11-hexahydronaphthacene-1-carboxylic acid methyl ester |
| aclacinomycin N | = 2-ethyl-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2S,5S,6S)-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-1,2,3,4,6,11-hexahydronaphthacene-1-carboxylic acid methyl ester |
| aclacinomycin T | = 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-{[2,3,6-trideoxy-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy}-1-naphthacenecarboxylic acid methyl ester |
| = methyl (1R,2R,4S)-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-4-{[2,3,6-trideoxy-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate |
| aclacinomycin Y | = 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R,6S)-5,6-dihydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]naphthacene-1-carboxylic acid methyl ester |
| acylceramide | = ω-O-acylceramide |
| = ceramide that contains an ultra-long-chain ω-hydroxyfatty acid moiety (C28-C36) that is further extended by ω-esterification with linoleic acid. |
| ADP-D-ribose | = adenosine 5′-(5-deoxy-D-ribofuranos-5-yl diphosphate) |
| aequorin | = the non-covalent complex formed by apoaequorin polypeptide and coelenterazine-2-hydroperoxide. |
| aflatoxin B1 | = (6aR,9aS)-4-methoxy-2,3,6a,9a-tetrahydrocyclopenta[c]furo[3′,2′:4,5]furo[2,3-h][1]benzopyran-1,11-dione |
| aflatoxin B2 | = (6aR,9aS)-4-methoxy-2,3,6a,8,9,9a-hexahydrocyclopenta[c]furo[3′,2′:4,5]furo[2,3-h][1]benzopyran-1,11-dione |
| agaritine | = (γ-L-glutamyl)-N1-(4-hydroxymethylphenyl)hydrazine |
| aklanonate | = [4,5-dihydroxy-9,10-dioxo-3-(3-oxopentanoyl)-9,10-dihydroanthracen-2-yl]acetic acid |
| aklaviketone | = methyl (1R,2R)-2-ethyl-2,5,7-trihydroxy-4,6,11-trioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate |
| aklavinone | = methyl (1R,2R,4S)-2-ethyl-2,4,5,7-tetrahydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate |
| alachlor | = N-(methoxymethyl)-2-chloro-N-(2,6-diethylphenyl)acetamide |
| D-alanyl-(R)-lactate | = D-alanyl-D-lactate |
| = (2R)-2-(D-alanyloxy)propanoic acid |
| = (R)-2-((R)-2-aminopropanoyloxy)propanoic acid |
| albendazole | = methyl [5-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate |
| albonoursin | = (3Z,6Z)-3-benzylidene-6-(2-methylpropylidene)piperazine-2,5-dione |
| alginate | = linear polymer of β-D-mannuronate residues linked by (1-4) linkages, with variable amounts of its C-5 epimer α-L-guluronate. |
| alizarin | = 1,2-dihydroxy-9,10-anthraquinone |
| allocitrate | = (1S,2S)-1-hydroxypropane-1,2,3-tricarboxylate |
| = D-erythro-isocitrate |
| L-altrarate | = L-talarate |
| = (2R,3R,4S,5R)-2,3,4,5-tetrahydroxyhexanedioate |
| 6-amino-6-deoxyfutalosine | = 3-{3-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]propanoyl}benzoate |
| aminopentol | = (2S,3S,5R,10R,12S,14S,15R,16R)-2-amino-12,16-dimethylicosane-3,5,10,14,15-pentol |
| ammelide | = 6-amino-1,3,5-triazine-2,4-diol |
| ammeline | = 4,6-diamino-1,3,5-triazin-2-ol |
| (–)-α-amorphene | = (1S,4aR,8aS)-4,7-dimethyl-1-(propan-2-yl)-1,2,4a,5,6,8a-hexahydronaphthalene |
| AMP | = adenosine 5′-phosphate |
| anaerobilin | = (4Z,10Z,14E)-8,12-bis(2-carboxyethyl)-3,7,13,18-tetramethyl-1,2,17-trivinyl-23,24-dihydrobilin |
| anandamide | = (5Z,8Z,11Z,14Z)-N-(2-hydroxyethyl)icosa-5,8,11,14-tetraenamide |
| 1,5-anhydro-D-fructose | = 1,5-anhydro-D-arabino-hex-2-ulose |
| = (4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)dihydro-2H-pyran-3(4H)-one |
| anhydrotetracycline | = (4S,4aS,12aS)-4-(dimethylamino)-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-1,4,4a,5,12,12a-hexahydrotetracene-2-carboxamide |
| L-anticapsin | = 3-[(1R,2S,6R)-5-oxo-7-oxabicyclo[4.1.0]hept-2-yl]-L-alanine |
| β-D-apiose | = (2R,3R,4R)-4-(hydroxymethyl)tetrahydrofuran-2,3,4-triol |
| apo-[acyl-carrier protein] | = family of proteins or protein domains that contain a conserved serine residue, which are involved in acyl-group transfer. |
| App-tRNAHis | = 5′-(5′-diphosphoadenosine)-ribonucleotide-[tRNAHis] |
| apulose | = 1,3,4-trihydroxy-3-(hydroxymethyl)butan-2-one |
| 4′-α-L-Ara4N-α-Kdo-(2→4)-α-Kdo-(2→6)-lipid IVA | = 4-amino-4-deoxy-α-L-arabinopyranosyl 2-deoxy-2-[(3R)-3-hydroxytetradecanamido]-3-O-[(3R)-3-hydroxytetradecanoyl]-4-phospho-β-D-glucopyranosy-(1→6)-2-deoxy-2-[(3R)-3-hydroxytetradecanamido]-3-O-[(3R)-3-hydroxytetradecanoyl]-α-D-glucopyranosyl phosphate |
| Araf | = arabinofuranose |
| Arap | = arabinopyranose |
| arabidiol | = (13R)-malabarica-17,21-diene-3,14-diol |
| archaeine | = 7-deaza-7-carbamidoylguanine |
| = base G* |
| L-arogenate | = 1-[(2S)-2-amino-2-carboxyethyl]-4-hydroxycyclohexa-2,5-diene-1-carboxylate |
| aromadendrene | = (1aR,4aR,7R,7aR,7bS)-1,1,7-trimethyl-4-methylidenedecahydro-1H-cyclopropa[e]azulene |
| ascopyrone M | = 1,5-anhydro-4-deoxy-D-glycero-hex-3-en-2-ulose |
| = (6S)-4-hydroxy-6-(hydroxymethyl)-2H-pyran-3(6H)-one |
| ascopyrone P | = 1,5-anhydro-4-deoxy-D-glycero-hex-1-en-3-ulose |
| = (2S)-5-hydroxy-2-(hydroxymethyl)-2H-pyran-4(3H)-one |
| (3S)-(+)-asterisca-2(9),6-diene | = (4S,7Z)-2,2,4,7-tetramethyl-2,3,4,5,6,9-hexahydro-1H-cyclopenta[8]annulene |
| atrazine | = 6-chloro-N-ethyl-N′-isopropyl-1,3,5-triazine-2,4-diamine |
| aurachin B | = 2-methyl-4-[(2E,6E)-farnesyl]-3-quinolinol 1-oxide |
| aurachin C | = 1-hydroxy-2-methyl-3-[(2E,6E)-farnesyl]-4(1H)-quinolinone |
| aureothin | = 2-methoxy-3,5-dimethyl-6-[(2R,4Z)-4-[(2E)-2-methyl-3-(4-nitrophenyl)prop-2-en-1-ylidene]oxolan-2-yl]-4H-pyran-4-one |
| aureusidin | = 4,6-dihydroxy-2-[(3,4-dihydroxyphenyl)methylidene]benzofuran-3(2H)-one |
| autoinducer-2 | = AI-2 |
| = (2R,4S)-2-methyl-2,3,3,4-tetrahydroxytetrahydrofuran |
| avenacoside B | = (22S,25S)-3β-{β-D-glucopyranosyl-(1→3)-β-D-glucopyranosyl-(1→4)-[α-L-rhamnopyranosyl-(1→2)]-β-D-glucopyranosyloxy}-26-(β-D-glucopyranosyloxy)-22,25-epoxyfurost-5-ene |
| avenanthramide C | = 2-[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enamido]-5-hydroxybenzoate |
| averantin | = 1,3,6,8-tetrahydroxy-2-[(1S)-1-hydroxyhexyl]anthracene-9,10-dione |
| (1′S)-averantin | = 1,3,6,8-tetrahydroxy-[(1S)-2-hydroxyhexyl]-9,10-anthraquinone |
| averufin | = 7,9,11-trihydroxy-2-methyl-3,4,5,6-tetrahydro-2,6-epoxy-2H-anthra[2,3-b]oxocin-8,13-dione |
| (R)-axinyssene | = (4R)-4-[(5E)-6,10-dimethylundeca-1,5,9-trien-2-yl]-1-methylcyclohexene |
| azurin | = electron-transfer protein containing a type-1 copper site |
| bacilysin | = L-alanyl-3-[(1R,2S,6R)-5-oxo-7-oxabicyclo[4.1.0]hept-2-yl]-L-alanine |
| baicalein | = 5,6,7-trihydroxyflavone |
| = 5,6,7-trihydroxy-2-phenyl-4H-chromen-4-one |
| baicalin | = 5,6,7-trihydroxyflavone-7-O-β-D-glucuronate |
| = 5,6-dihydroxy-4-oxo-2-phenyl-4H-chromen-7-yl β-D-glucupyranosiduronic acid |
| benzil | = 1,2-diphenylethane-1,2-dione |
| (+)-exo-β-bergamotene | = β-trans-bergamotene |
| = (1S,5S,6R)-6-methyl-2-methylidene-6-(4-methylpent-3-enyl)bicyclo[3.1.1]heptane |
| (-)-exo-α-bergamotene | = (-)-trans-α-bergamotene |
| = (1S,5S,6R)-2,6-dimethyl-6-(4-methylpent-3-en-1-yl)bicyclo[3.1.1]hept-2-ene |
| betaine | = glycine betaine |
| = N,N,N-trimethylglycine |
| = N,N,N-trimethylammonioacetate |
| 3,8′-biflaviolin | = 2,3′,4,6′,7,8′-hexahydroxy-1,2′-binaphthalene-1′,4′,5,8-tetraone |
| 3,3′-biflaviolin | = 3,3′,6,6′,8,8′-hexahydroxy-2,2′-binaphthalene-1,1′,4,4′-tetraone |
| biliverdin-IX-β | = 3,7-bis(2-carboxyethyl)-2,8,12,17-tetramethyl-13,18-divinylbilin-1,19(21H,24H)-dione |
| biliverdin-IX-δ | = 3,7-bis(2-carboxyethyl)-2,8,13,18-tetramethyl-12,17-divinylbilin-1,19(21H,24H)-dione |
| biotin | = 5[(3aS,4S,6aR)-2-oxohexahydro(4H-thieno[4,5-d]imidazol-4-yl)]pentanoate |
| bisanhydrobacterioruberin | = (2S,2S′)-2,2′-bis(3-methylbut-2-en-1-yl)-3,4-didehydro-1,1′,2,2′-tetrahydro-ψ,ψ-carotene-1,1′-diol |
| biuret | = imidodicarbonic diamide |
| bracteatin | = 4,6-dihydroxy-2-[(3,4,5-trihydroxyphenyl)methylidene]benzofuran-3(2H)-one |
| brevianamide F | = (3S,8aS)-3-(1H-indol-3-ylmethyl)hexahydropyrrolo[1,2-a]pyrazine-1,4-dione |
| (–)-bursehernin | = (3R,4R)-4-(2H-1,3-benzodioxol-5-ylmethyl)-3-[(3,4-dimethoxyphenyl)methyl]oxolan-2-one |
| butachlor | = N-(butoxymethyl)-2-chloro-N-(2,6-diethylphenyl)acetamide |
| c-di-GMP | = c-di-guanylate |
| = cyclic di-3′,5′-guanylate |
| = cyclic-bis(3′→5′) dimeric GMP |
| C30 botryococcene | = (10S,13R)-10-ethenyl-2,6,10,13,17,21-hexamethyldocosa-2,5,11,16,20-pentaene |
| (-)-δ-cadinene | = (1R,8aS)-4,7-dimethyl-1-(propan-2-yl)-1,2,3,5,6,8a-hexahydronaphthalene |
| 2-O-caffeoylisocitrate | = (1R,2S)-1-{[3-(E)-(3,4-dihydroxyphenyl)acryloyl]oxy}propane-1,2,3-tricarboxylate |
| = (3S,4R)-3-carboxy-2,3-dideoxy-4-O-[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]pentarate |
| calcidiol | = 25-hydroxyvitamin D3 |
| = (3S,5Z,7E)-9,10-seco-5,7,10(19)-cholestatriene-3,25-diol |
| calciol | = cholecalciferol |
| = vitamin D3 |
| = (3S,5Z,7E)-9,10-seco-5,7,10(19)-cholestatriene-3-ol |
| calcitetrol | = 1α,(24R),25-dihydroxyvitamin D3 |
| = (1S,3R,5Z,7E,24R,25)-9,10-secocholesta-5,7,10(19)-triene-1,3,24,25-tetrol |
| calcitetrol | = 1α,24R,25-trihydroxyvitamin D3 |
| = (1S,3R,5Z,7E,24R)-9,10-seco-5,7,10(19)-cholestatriene-1,3,24,25-tetrol |
| calcitriol | = 1α,25-dihydroxyvitamin D3 |
| = (1S,3R,5Z,7E)-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol |
| caldariellaquinol | = 6-(3,7,11,15,19,23-hexamethyltetracosyl)-5-(methylsulfanyl)-1-benzothiophene-4,7-diol |
| caldopentamine | = N-(3-aminopropyl)-N′-{3-[(3-aminopropyl)amino]propyl}-1,3-propanediamine |
| calendate | = (8E,10E,12Z)-octadeca-8,10,12-trienoate |
| (+)-camphene | = (1R,4S)-2,2-dimethyl-3-methylenebicyclo[2.2.1]heptane |
| (-)-camphene | = (1S,4R)-2,2-dimethyl-3-methylenebicyclo[2.2.1]heptane |
| α-campholonate | = (4-hydroxy-2,2,3-trimethylcyclopent-3-enyl)acetate (enol form) |
| = (2,2,3-trimethyl-4-oxocyclopentyl)acetate (keto form) |
| cannabidiolate | = 2,4-dihydroxy-3-[(1R,6R)-3-methyl-6-(prop-1-en-2-yl)cyclohex-2-en-1-yl]-6-pentylbenzoate |
| cannabigerolate | = CBGA |
| = 3-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-2,4-dihydroxy-6-pentylbenzoate |
| cannabinerolate | = 3-[(2Z)-3,7-dimethylocta-2,6-dien-1-yl]-2,4-dihydroxy-6-pentylbenzoate |
| captopril | = (2S)-1-(2-methyl-3-sulfanylpropanoyl)-L-proline |
| 6′′-O-carbamoylkanamycin A | = (1S,2R,3R,4S,6R)-4,6-diamino-3-[(6-amino-6-deoxy-α-D-glucopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-6-O-carbamoyl-3-deoxy-α-D-glucopyranoside |
| carbaryl | = N-methyl-1-naphthyl carbamate |
| carlactone | = 3-methyl-5-{[(1Z,3E)-2-methyl-4-(2,6,6-trimethylcyclohex-1-en-1-yl)buta-1,3-dien-1-yl]oxy}-5H-furan-2-one |
| carminate | = 7-(β-D-glucopyranosyl)-3,5,6,8-tetrahydroxy-1-methyl-9,10-dioxo-9,10-dihydroanthracene-2-carboxylate |
| carminomycin | = (1S,3S)-3-acetyl-3,5,10,12-tetrahydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside |
| = (1S,3S)-3-acetyl-3,5,10,12-tetrahydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside |
| L-carnitine | = (3R)-3-hydroxy-4-(trimethylammonio)butanoate |
| carnitine | = 3-hydroxy-4-(trimethylammonio)butanoate |
| carubicin | = (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside |
| (–)-carvone | = (4R)-mentha-1(6),8-dien-6-one |
| = (5R)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one |
| CDP | = cytidine diphosphate |
| CDP-α-D-paratose | = CDP-3,6-dideoxy-α-D-glucose |
| = CDP-3,6-dideoxy-α-D-ribo-hexose |
| CDP-α-D-tyvelose | = CDP-3,6-dideoxy-α-D-mannose |
| = CDP-3,6-dideoxy-α-D-arabino-hexose |
| cembrene A | = (1E,5E,9E,12R)-1,5,9-trimethyl-12-(propan-2-en-2-yl)cyclotetradeca-1,5,9-triene |
| cembrene C | = (1E,5E,9E)-1,5,9-trimethyl-12-(propan-2-ylidene)cyclotetradeca-1,5,9-triene |
| ceramide | = N-acylsphingoid. The fatty acids of naturally occurring ceramides range in chain length from about C16 to about C26 and may contain one or more double bonds and/or hydroxy substituents at C-2 |
| chanoclavine-I | = (1E)-2-methyl-3-[(4R,5R)-4-(methylamino)-1,3,4,5-tetrahydrobenz[cd]indol-5-yl]prop-2-en-1-ol |
| chanoclavine-I aldehyde | = (1E)-2-methyl-3-[(4R,5R)-4-(methylamino)-1,3,4,5-tetrahydrobenz[cd]indol-5-yl]prop-2-enal |
| (S)-cheilanthifoline | = (6aS)-9-methoxy-6,11,12,14-tetrahydro-2H,6aH-[1,3]dioxolo[4,5-h]isoquino[2,1-b]isoquinolin-8-ol |
| chelirubine | = 5-methoxy-13-methyl-2H,10H-[1,3]dioxolo[4,5-i][1,3]dioxolo[4′,5′:4,5]benzo[1,2-c]phenanthridinium |
| chitin | = [(1→4)-β-D-GlcpNAc]n |
| = (1→4)-2-acetamido-2-deoxy-β-D-glucan |
| chitin | = [(1→4)-N-acetyl-β-D-glucosaminyl]n |
| cholate | = 3α,7α,12α-trihydroxy-5β-cholan-24-oate |
| cholate | = 3α,7α-12α-trihydroxy-5β-cholan-24-oate |
| choline | = (2-hydroxyethyl)trimethylammonium |
| choloyl-CoA | = 3α,7α,12α-trihydroxy-5β-cholan-24-oyl-CoA |
| chorismate | = (3R,4R)-3-[(1-carboxyethenyl)oxy]-4-hydroxycyclohexa-1,5-diene-1-carboxylate |
| chrysanthemic acid | = 2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropane-1-carboxylic acid |
| chrysanthemyl | = [2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropyl]methyl |
| 1,8-cineole | = 1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane |
| citrate | = 2-hydroxypropane-1,2,3-tricarboxylate |
| citryl | = 3-hydroxy-3,4-dicarboxybutanoyl |
| CMP | = cytidine monophosphate |
| CMP-β-Kdo | = CMP-3-deoxy-β-D-manno-oct-2-ulopyranosylonate |
| CMP-β-Kdo | = CMP-3-deoxy-β-D-manno-octulosonate |
| = CMP-3-deoxy-β-D-manno-oct-2-ulopyranosylonate |
| CoB | = coenzyme B |
| = N-(7-sulfanylheptanoyl)threonine |
| = N-(7-mercaptoheptanoyl)threonine (deprecated) |
| CoB | = coenzyme B |
| = N-(7-sulfanylheptanoyl)threonine |
| = N-(7-mercaptoheptanoyl)threonine 3-O-phosphate (deprecated) |
| codeinone | = 3-methoxy-17-methyl-7,8-didehydro-4,5α-epoxymorphinan-6-one |
| coelenteramide | = N-[3-benzyl-5-(4-hydroxyphenyl)pyrazin-2-yl]-2-(4-hydroxyphenyl)acetamide |
| coelenteramide h | = Renilla oxyluciferin |
| = N-[3-benzyl-5-(4-hydroxyphenyl)pyrazin-2-yl]-2-phenylacetamide |
| coelenterazine | = 8-benzyl-2-(4-hydroxybenzyl)-6-(4-hydroxyphenyl)imidazo[1,2-a]pyrazin-3(7H)-one |
| coelenterazine h | = Renilla luciferin |
| = 2,8-dibenzyl-6-(4-hydroxyphenyl)imidazo[1,2-a]pyrazin-3(7H)-one |
| coelimycin P1 | = N-[(3R)-8-[(2E)-but-2-enoyl]-2-oxo-6-[(2E)-1,2,5,6-tetrahydropyridin-2-ylidene]-2,3,4,6-tetrahydro-1,5-oxathiocin-3-yl]acetamide |
| coelimycin P1 | = N-[(3R)-8-[(2E)-but-2-enoyl]-6-[(2E)-5,6-dihydropyridin-2(1H)-ylidene]-2-oxo-3,4-dihydro-2H,6H-1,5-oxathiocin-3-yl]acetamide |
| colneleate | = (8E)-9-[(1E,3Z)-nona-1,3-dien-1-yloxy]non-8-enoate |
| CoM | = coenzyme M |
| = 2-sulfanylethane-1-sulfonate |
| CoM | = coenzyme M |
| = 2-sulfanylethane-1-sulfonate |
| = 2-mercaptoethanesulfonate (deprecated) |
| CoM-S-S-CoB | = CoB-CoM heterodisulfide |
| = N-{7-[(2-sulfoethyl)dithio]heptanoyl}-O3-phospho-L-threonine = |
| CoM-S-S-CoB | = CoB-CoM heterodisulfide |
| = N-{7-[(2-sulfoethyl)dithio]heptanoyl}-O3-phospho-L-threonine |
| = O3-phospho-N-{7-[2-(2-sulfoethyl)disulfan-1-yl]heptanoyl}-L-threonine |
| coniferonate | = (5Z,9Z,12Z,15Z)-octadeca-5,9,12,15-tetraenoate |
| (-)-α-copaene | = (1R,2S,6S,7S,8S)-1,3-dimethyl-8-(propan-2-yl)tricyclo[4.4.0.02,7]dec-3-ene |
| (+)-copalyl diphosphate | = (2E)-3-methyl-5-[(1S,4aS,8aS)-5,5,8a-trimethyl-2-methylidenedecahydronaphthalen-1-yl]pent-2-en-1-yl trihydrogen diphosphate |
| 9α-copalyl diphosphate | = syn-copalyl diphosphate |
| = (2E)-3-methyl-5-[(1R,4aS,8aS)-5,5,8a-trimethyl-2-methylidenedecahydronaphthalen-1-yl]pent-2-en-1-yl trihydrogen diphosphate |
| core 1 | = O3-[β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl]-L-seryl/threonyl-[protein] |
| core 2 | = 3-O-{β-D-galactosyl-(1→3)-[N-acetyl-β-D-glucosaminyl-(1→6)]-N-acetyl-α-D-galactosaminyl}-L-seryl/threonyl-[protein] |
| core 2 | = O3-{β-D-galactosyl-(1→3)-[N-acetyl-β-D-glucosaminyl-(1→6)]-N-acetyl-α-D-galactosaminyl}-L-seryl/threonyl-[protein] |
| (+)-corvol ether A | = (1R,4S,4aR,7R,8aR)-4,7-dimethyl-1-(propan-2-yl)decahydro-1,7-epoxynaphthalene |
| (+)-corvol ether B | = (1S,3R,5aR,6S,8aR)-3,6-dimethyl-1-(propan-2-yl)hexahydro-1H,3H-3,8a-methanocyclopenta[c]oxepine |
| (S)-corytuberine | = (6aS)-2,10-dimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-1,11-diol |
| crocetin | = (2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate |
| crocin | = bis(β-D-gentiobiosyl) crocetin |
| cThz*-P | = 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate |
| cThz-P | = 2-(2-carboxy-4-methylthiazol-5-yl)ethyl phosphate |
| = 4-methyl-5-[2-(phosphonooxy)ethyl]-1,3-thiazole-2-carboxylate |
| 4-epi-cubebol | = (3S,3aS,3bR,4S,7S,7aS)-4-(2-hydroxypropan-2-yl)-7-methyloctahydro-1H-cyclopenta[1,3]cyclopropa[1,2]benzen-3-ol |
| curcumin | = (1E,6E)-5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,4,6-trien-3-one |
| cyanidin | = 3,3′,4′,5,7-pentahydroxyflavylium |
| cyanophycin | = [L-Asp(4-L-Arg)]n |
| = N-β-aspartylarginine |
| = [L-4-(L-arginin-2-N-yl)aspartic acid]n |
| cyanophycin | = [L-Asp(4-L-Arg)]n |
| = N-β-aspartylarginine |
| = [L-4-(L-arginin-2-N-yl)aspartic acid]n |
| cyanuric acid | = 1,3,5-triazine-2,4,6(1H,3H,5H)-trione |
| = 2,4,6-trihydroxy-s-triazine |
| (–)-cyatha-3,12-diene | = (3aS,5aS,10aS)-3a,5a,8-trimethyl-1-(propan-2-yl)-2,3,4,5,6,9,10,10a-octahydrocyclohepta[e]indene |
| cyclic pyranopterin phosphate | = cPMP |
| = precursor Z |
| = 8-amino-2,12,12-trihydroxy-4a,5a,6,9,11,11a,12,12a-octahydro[1,3,2]dioxaphosphinino[4′,5′:5,6]pyrano[3,2-g]pteridin-10(4H)-one 2-oxide |
| cycloaraneosene | = (1R,3aR,9aS,10aR)-1,9a-dimethyl-4-methylene-7-(propan-2-yl)-1,2,3,3a,4,5,6,8,9,9a,10,10a-dodecahydrodicyclopenta[a,d][8]annulene |
| cyclooctat-9-en-7-ol | = (1R,3aR,4S,7R,9aR,10aR)-1,4,9a-trimethyl-7-(propan-2-yl)-1,2,3,3a,4,5,7,8,9,9a,10,10a-dodecahydrodicyclopenta[a,d][8]annulen-4-ol |
| cyclooctat-9-en-7-ol | = (1S,3aS,4R,7S,9aS,10aS)-1,4,9a-trimethyl-7-(propan-2-yl)-1,2,3,3a,4,5,7,8,9,9a,10,10a-dodecahydrodicyclopenta[a,d][8]annulen-4-ol |
| cyclooctat-9-ene-5,7-diol | = (1S,3R,3aS,4R,7S,9aS,10aS)-1,4,9a-trimethyl-7-(propan-2-yl)-1,2,3,3a,4,5,7,8,9,9a,10,10a-dodecahydrodicyclopenta[a,d][8]annulene-3,4-diol |
| cyclooctatin | = cycloctat-9-ene-5,7,18-triol |
| = (1R,3R,3aS,4R,7S,9aS,10aS)-1-(hydroxymethyl-)4,9a-dimethyl-7-(propan-2-yl)-1,2,3,3a,4,5,7,8,9,9a,10,10a-dodecahydrodicyclopenta[a,d][8]annulene-3,4-diol |
| (–)-cyclopenine | = (3S,3′R)-4-methyl-3′-phenyl-1H-spiro[1,4-benzodiazepine-3,2′-oxirane]-2,5-dione |
| cyclopeptine | = (3S)-3-benzyl-4-methyl-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione |
| cylindrospermopsin | = (2aS,3R,4S,5aS,7R)-7-[(R)-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)(hydroxy)methyl]-3-methyl-2a,3,4,5,5a,6,7,8-octahydro-2H-1,8,8b-triazaacenaphthylen-4-yl hydrogen sulfate |
| p-cymene | = 4-methyl-1-(propan-2-yl)benzene |
| dapdiamide A | = 3-{[(2E)-4-amino-4-oxobut-2-enoyl]amino}-L-alanyl-L-valine |
| dapdiamide B | = 3-{[(2E)-4-amino-4-oxobut-2-enoyl]amino}-L-alanyl-L-isoleucine |
| dapdiamide C | = 3-{[(2E)-4-amino-4-oxobut-2-enoyl]amino}-L-alanyl-L-leucine |
| daturadiol | = 6β-hydroxy-β-amyrin |
| = olean-12-ene-3β,6β-diol |
| daunorubicin | = (+)-daunomycin |
| = (8S,10S)-8-acetyl-10-[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,8,11-trihydroxy-1-methoxy-9,10-dihydro-7H-tetracene-5,12-dione |
| daunorubicin | = (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside |
| dCDP | = deoxycytidine diphosphate |
| dCMP | = deoxycytidine monophosphate |
| decarbamoylnovobiocin | = N-{7-[(6-deoxy-5-methyl-4-O-methyl-β-D-gulopyranosyl)oxy]4-hydroxy-8-methyl-2-oxo-2H-chromen-3-yl}-4-hydroxy-3-(3-methyl-2-buten-1-yl)benzamide |
| dehydro coenzyme F420-0 | = 2-{[5-deoxy-5-(8-hydroxy-2,4-dioxopyrimidino[4,5-b]quinolin-10(2H)-yl)-L-ribityloxy]hydroxyphosphoryloxy}prop-2-enoate |
| 2′-dehydrokanamycin A | = (1S,2R,3R,4S,6R)-4,6-diamino-3-[(6-amino-6-deoxy-α-D-arabino-hexopyranosyl-2-ulose)oxy]-2-hydroxycyclohexyl 3-amino-3-deoxy-α-D-glucopyranoside |
| 12-dehydrotetracycline | = (4S,4aS,6S,12aS)-4-(dimethylamino)-3,6,10,12a-tetrahydroxy-6-methyl-1,11,12-trioxo-1,4,4a,5,6,11,12,12a-octahydrotetracene-2-carboxamide |
| 15-demethoxyaclacinomycin T | = (1R,2R,4S)-2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-{[2,3,6-trideoxy-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy}-1-naphthacenecarboxylic acid |
| = (1R,2R,4S)-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-4-{[2,3,6-trideoxy-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydrotetracene-1-carboxylic acid |
| demethoxycurcumin | = (1E,6E)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)hepta-1,4,6-trien-3-one |
| 8-demethyl-8-α-L-rhamnosyltetracenomycin C | = methyl (6aR,7S,10aR)-6a,7,10a,12-tetrahydroxy-8-methoxy-1-methyl-6,10,11-trioxo-3-α-L-rhamnosyloxy-6,6a,7,10,10a,11-hexahydrotetracene-2-carboxylate |
| demethyldecarbamoyl novobiocin | = N-{7-[(6-deoxy-5-methyl-β-D-gulopyranosyl)oxy]-4-hydroxy-8-methyl-2-oxo-2H-chromen-3-yl}-4-hydroxy-3-(3-methylbut-2-en-1-yl)benzamide |
| demethyldecarbamoylnovobiocin | = N-{7-[(6-deoxy-5-methyl-β-D-gulopyranosyl)oxy]-4-hydroxy-8-methyl-2-oxo-2H-chromen-3-yl}-4-hydroxy-3-(3-methylbut-2-en-1-yl)benzamide |
| (–)-4′-demethyldeoxypodophyllotoxin | = (5R,5aR,8aR)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one |
| demethyldeoxyspectinabilin | = 2-hydroxy-3,5-dimethyl-6-[(3E,5E,7E,9E)-3,5,7,9-tetramethyl-10-(4-nitrophenyl)deca-3,5,7,9-tetraen-1-yl]pyran-4-one |
| (–)-4′-demethylepipodophyllotoxin | = (5R,5aR,8aR,9S)-9-hydroxy-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one |
| demethyllactenocin | = [(2R,3R,4E,6E,9R,11R,12S,13S,14R)-12-{[3,6-dideoxy-3-(dimethylamino)-D-glucopyranosyl]oxy}-2-ethyl-14-hydroxy-5,9,13-trimethyl-8,16-dioxo-11-(2-oxoethyl)oxacyclohexadeca-4,6-dien-3-yl]methyl 6-deoxy-β-D-allopyranoside |
| demethyllactenocin | = [(2R,3R,4E,6E,9R,11R,12S,13S,14R)-12-{[3,6-dideoxy-3-(dimethylamino)-D-glucopyranosyl]oxy}-2-ethyl-14-hydroxy-5,9,13-trimethyl-8,16-dioxo-11-(2-oxoethyl)oxacyclohexadeca-4,6-dien-3-yl]methyl 6-deoxy-D-allopyranoside |
| demethylluteothin | = nordeoxyaureothin |
| = 2-[(3E,5E)-3,5-dimethyl-6-(4-nitrophenyl)hexa-3,5-dien-1-yl]-6-hydroxy-3,5-dimethyl-4H-pyran-4-one |
| (+)-demethylpiperitol | = 4-[(1S,3aR,4S,6aR)-4-(1,3-benzodioxol-5-yl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]benzene-1,2-diol |
| demethylsulochrin | = 2-(2,6-dihydroxy-4-methylbenzoyl)-5-hydroxy-3-methoxybenzoic acid |
| 4-demethylwyosine | = imG-14 |
| = 6-methyl-3-(β-D-ribofuranosyl)-3,5-dihydro-9H-imidazo[1,2-a]purin-9-one |
| (–)-5′-demethylyatein | = (3R,4R)-4-(2,3-benzodioxol-5-ylmethyl)-3-(3-hydroxy-4,5-dimethoxybenzyl)dihydrofuran-2(3H)-one |
| (–)-5′-demethylyatein | = (3R,4R)-4-(2H-1,3-benzodioxol-5-ylmethyl)-3-[(3-hydroxy-4,5-dimethoxyphenyl)methyl]oxolan-2-one |
| β-D-4-deoxy-Δ4-GlcAp-(1→3)-D-GalNAc | = 3-(4-deoxy-β-D-gluc-4-enuronosyl)-N-acetyl-D-galactosamine |
| = 3-(4-deoxy-α-L-threo-hex-4-enopyranosyluronic acid)-2-acetamido-2-deoxy-D-galactose |
| 1-deoxy-11β-hydroxypentalenate | = (1S,2R,3aR,5aS,8aR)-2-hydroxy-1,7,7-trimethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene-4-carboxylate |
| 1-deoxy-11-oxopentalenate | = (1S,3aR,5aS)-1,7,7-trimethyl-2-oxo-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene-4-carboxylate |
| deoxybrevianamide E | = (3S,8aS)-3-{[2-(2-methylbut-3-en-2-yl)-1H-indol-3-yl]methyl}-octahydropyrrolo[1,2-a]piperazine-1,4-dione |
| 13-deoxydaunorubicin | = (1S,3S)-3-ethyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside |
| 7-deoxyloganetate | = (1S,4aS,7S,7aR)-1-hydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylate |
| deoxynogalonate | = [4,5-dihydroxy-10-oxo-3-(3-oxobutanoyl)-9,10-dihydroanthracen-2-yl]acetate |
| 1-deoxypentalenate | = (1R,3aR,5aS,8aR)-1,7,7-trimethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene-4-carboxylate |
| (–)-deoxypodophyllotoxin | = (5R,5aR,8aR)-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-6(5a)-one |
| 26-desgluco-avenacoside B | = (22S,25S)-3β-{β-D-glucopyranosyl-(1→3)-β-D-glucopyranosyl-(1→4)-[α-L-rhamnopyranosyl-(1→2)]-β-D-glucopyranosyloxy}-22,25-epoxyfurost-5-en-26-ol |
| desmethylxanthohumol | = 2′,4,4′,6′-tetrahydroxy-3-prenylchalcone |
| = (2E)-3-(4-hydroxyphenyl)-1-[2,4,6-trihydroxy-3-(3-methylbut-2-en-1-yl)phenyl]prop-2-en-1-one |
| desulfo-A47934 | = LY 154989 |
| = 7-demethyl-64-O-demethyl-19-deoxy-22,31,45-trichloro-11-sulfo-ristomycin A aglycone |
| dhurrin | = (S)-4-hydroxymandelonitrile β-D-glucoside |
| DIBOA glucoside | = (2R)-4-hydroxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl β-D-glucopyranoside |
| dichloroindophenol | = DCPIP |
| = 2,6-dichloro-4-[(4-hydroxyphenyl)imino]cyclohexa-2,5-dien-1-one |
| dicranin | = (9Z,12Z,15Z)-octadeca-9,12,15-trien-6-ynoic acid |
| (+)-didemethylpinoresinol | = 4-[(1S,3aR,4S,6aR)-4-(3,4-dihydroxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]benzene-1,2-diol |
| digallate | = 3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyloxy)benzoate |
| diglucosyl-(2,3-dihydroxybenzoylserine)3 | = salmochelin S2 |
| = O-3-{O-3-[N-(2,3-dihydroxybenzoyl)-C-5-deoxy-β-D-glucosyl-L-seryl]-N-(2,3-dihydroxybenzoyl)-C-5-deoxy-β-D-glucosyl-L-seryl}-N-(2,3-dihydroxybenzoyl)-L-serine |
| diglucosyl-enterobactin | = N-(2,3-dihydroxybenzoyl)-O-[N-(5-β-D-glucopyranosyl-2,3-dihydroxybenzoyl)-O-[N-(5-β-D-glucopyranosyl-2,3-dihydroxybenzoyl)-L-seryl]-L-seryl]-L-serine-(3→1(3))-lactone |
| = salmochelin S4 |
| = di-C-glucosyl-enterobactin |
| diglucosyl-enterobactin | = N-(2,3-dihydroxybenzoyl)-O-[N-(5-β-D-glucopyranosyl-2,3-dihydroxybenzoyl)-O-[N-(5-β-D-glucopyranosyl-2,3-dihydroxybenzoyl)-L-seryl]-L-seryl]-L-serine-[3→1(3)]-lactone |
| = salmochelin S4 |
| = di-C-glucosyl-enterobactin |
| dihydrobisanhydrobacterioruberin | = (2S,2S′)-2,2′-bis(3-methylbut-2-en-1-yl)-3,3′,4,4′-tetradehydro-1,1′,2,2′-tetrahydro-ψ,ψ-carotene-1,1′-diol |
| dihydrobisanhydrobacterioruberin | = (2S,2S′)-2,2′-bis(3-methylbut-2-en-1-yl)-3,3′,4,4′-tetradehydro-1,1′,2,2′-tetrahydro-ψ,ψ-carotene-1,1′-diol |
| = (3S,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E,24E,26E,30R)-2,6,10,14,19,23,27,31-octamethyl-3,30-bis(3-methylbut-2-en-1-yl)dotriaconta-4,6,8,10,12,14,16,18,20,22,24,26-dodecaene-2,31-diol |
| dihydrochelirubine | = 5-methoxy-13-methyl-13,14-dihydro-2H,10H-[1,3]dioxolo[4,5-i][1,3]dioxolo[4′,5′:4,5]benzo[1,2-c]phenanthridinium |
| 13-dihydrodaunorubicin | = daunorubicinol |
| = (1S,3S)-3,5,12-trihydroxy-3-(1-hydroxyethyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside |
| β-dihydromenaquinone-9 | = MK-9(II-H2) |
| = 2-methyl-3-[(2E,10E,14E,18E,22E,26E,30E,33E)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,10,14,18,22,26,30,33-octaen-1-yl]naphthalene-1,4-dione |
| β-dihydromenaquinone-9 | = MK-9(II-H2) |
| = 2-methyl-3-[(2E,10E,14E,18E,22E,26E,30E,33E)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,10,14,18,22,26,30,33-octaen-1-yl]naphthalene-1,4-dione |
| dihydromethanophenazine | = 2-{[(6E,10E,14E)-3,7,11,15,19-pentamethylicosa-6,10,14,18-tetraen-1-yl]oxy}-5,10-dihydrophenazine |
| dihydromonacolin L acid | = (3R,5R)-7-[(1S,2S,4aR,6R,8aS)-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate |
| dihydromonacolin L acid | = (3R,5R)-7-[(1S,2S,4aR,6R,8aS)-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen1yl]-3,5-dihydroxyheptanoate |
| 7,8-dihydroneopterin 2′,3′-cyclic phosphate | = 2-amino-6-{(S)-hydroxy[(4R)-2-hydroxy-2-oxido-1,3,2-dioxaphospholan-4-yl]methyl}-7,8-dihydropteridin-4(1H)-one |
| = 2-amino-6-[(1S,2R)-1,2,3-trihydroxypropyl]-7,8-dihydro-4(1H)-pteridinone 1,2-cyclic phosphate |
| dihydrosanguinarine | = 13-methyl-13,14-dihydro-2H,10H-[1,3]dioxolo[4,5-i][1,3]dioxolo[4′,5′:4,5]benzo[1,2-c]phenanthridine |
| 12α,13α-dihydroxyfumitremorgin | = (5aR,6S,12S,14aS)-5a,6-dihydroxy-9-methoxy-12-(2-methylprop-1-en-1-yl)-1,2,3,5a,6,11,12,14a-octahydro-5H,14H-pyrrolo[1′′,2′′:4′,5′]pyrazino[1′,2′:1,6]pyrido[3,4-b]indole-5,14-dione |
| DIMBOA glucoside | = (2R)-4-hydroxy-7-methoxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl β-D-glucopyranoside |
| diNAcBac | = N,N′-diacetyl-D-bacillosamine |
| = 2,4-diacetamido-2,4,6-trideoxy-D-glucopyranose |
| dinoflagellate luciferin | = (1S,2S,3S)-1-carboxy-3-(2-carboxyethyl)-12-ethyl-2,8,13,18-tetramethyl-17-vinyl-1,2,3,21-tetrahydro-5,7-ethanobilene-a-19(16H),52-dione |
| diphthamide | = 2-[4-amino-4-oxo-3-(trimethylammonio)butyl]-L-histidine |
| diphthine | = 2-[(3S)-3-carboxy-3-(trimethylamino)propyl]-L-histidine |
| diphthine | = 2-[(3S)-3-carboxy-3-(trimethylammonio)propyl]-L-histidine |
| discadenine | = 3-(3-amino-3-carboxypropyl)-N6-(Δ2-isopentenyl)-adenine |
| docosahexaenoate | = (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate |
| (3E,7E)-dolabella-3,7-dien-18-ol | = 2-[(1R,3aR,5E,9E,12aR)-3a,6,10-trimethyl-1,2,3,3a,4,7,8,11,12,12a-decahydrocyclopenta[11]annulen-1-yl]propan-2-ol |
| dolabradiene | = (4aS,4bR,7S,8aR,10aS)-7-ethenyl-4b,7,10a-trimethyl-1-methylidene-decahydrophenanthrene |
| dolabradiene | = (4aS,4bR,7S,8aR,10aS)-7-ethenyl-4b,7,10a-trimethyl-1-methylidenetetradecahydrophenanthrene |
| (3E,7E)-dolathalia-3,7,11-triene | = (7E,11E)-3,3,7,11,13a-pentamethy1-2,3,5,6,9,10,13,13a-octahydro-1H-benzo[11]annulene |
| L-dopa | = 3,4-dihydroxy-L-phenylalanine |
| L-dopa | = 3,4-dihydroxyphenylalanine |
| D-dopachrome | = (2R)-5,6-dioxo-2,3,5,6-tetrahydro-1H-indole-2-carboxylate |
| L-dopachrome | = (2S)-5,6-dioxo-2,3,5,6-tetrahydro-1H-indole-2-carboxylate |
| dopamine | = 4-(2-aminoethyl)benzene-1,2-diol |
| dTMP | = thymidine 5′-phosphate |
| dZTP | = 2-amino-2′-deoxyadenosine 5′-triphosphate |
| ecgonine methyl ester | = 2β-carbomethoxy-3β-tropine |
| = methyl (1R,2R,3S,5S)-3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate |
| ecgonone methyl ester | = 2β-carbomethoxy-3-tropinone |
| = methyl (1R,2R,5S)-8-methyl-3-oxo-8-azabicyclo[3.2.1]octane-2-carboxylate |
| ectoine | = (4S)-2-methyl-1,4,5,6-tetrahydropyrimidine-4-carboxylate |
| EGF | = epidermal growth factor |
| EGF-like domain | = evolutionary conserved domain containing 30 to 40 amino-acid residues first described from epidermal growth factor |
| emodin | = 1,3,8-trihydroxy-6-methyl-9,10-anthraquinone |
| L-enduracididine | = 3-[(4R)-2-iminoimidazolidin-4-yl]-L-alanine |
| = 2-amino-3-[(2S)-iminoimidazolin-4-yl]propanoic acid |
| enterobactin | = N-(2,3-dihydroxybenzoyl)-O-[N-(2,3-dihydroxybenzoyl)-O-[N-(2,3-dihydroxybenzoyl)-L-seryl]-L-seryl]-L-serine-(3→1(3))-lactone |
| (–)-5-epieremophilene | = (3R,4aS,5S)-4a,5-dimethyl-3-(prop-1-en-2-yl)-1,2,3,4,4a,5,6,7-octahydronaphthalene |
| 7-epizingiberene | = (5R)-2-methyl-5-[(2R)-6-methylhept-5-en-2-yl]cyclohexa-1,3-diene |
| (+)-eremophilene | = (3S,4aS,5R)-4a,5-dimethyl-3-(prop-1-en-2-yl)-1,2,3,4,4a,5,6,7-octahydronaphthalene |
| ergothioneine | = Nα,Nα,Nα-trimethyl-2-sulfanylidene-2,3-dihydro-L-histidine |
| erythromycin D | = (3R,4S,5S,6R,7R,9R,11R,12S,13R,14R)-4-(2,6-dideoxy-3-C-methyl-α-L-ribo-hexopyranosyloxy)-14-ethyl-7,12-dihydroxy-6-[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyloxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione |
| esculetin | = 6,7-dihydroxy-1-benzopyran-2-one |
| = 6,7-dihydroxycoumarin |
| (-)-α-eudesmol | = 2-[(2R,4aR,8aR)-4a,8-dimethyl-1,2,3,4,4a,5,6,8a-octahydronaphthalen-2-yl]propan-2-ol |
| 10-epi-γ-eudesmol | = 2-[(2R,4aS)-4a,8-dimethyl-1,2,3,4,4a,5,6,7-octahydronaphthalen-2-yl]propan-2-ol |
| 7-epi-α-eudesmol | = 2-[(2S,4aR,8aR)-4a,8-dimethyl-1,2,3,4,4a,5,6,8a-octahydronaphthalen-2-yl]propan-2-ol |
| eupatolide | = 8β-hydroxygermacra-1(10),4,11(13)-trien-12,6α-lactone |
| factor 420 | = coenzyme F420 |
| = N-(N-{O-[5-(8-hydroxy-2,4-dioxo-2,3,4,10-tetrahydropyrimido[4,5-b]quinolin-10-yl)-5-deoxy-L-ribityl-1-phospho]-(S)-lactyl}-γ-L-glutamyl)-L-glutamate |
| farnesal | = 3,7,11-trimethyldodeca-2,6,10-trienal |
| farnesoate | = 3,7,11-trimethyldodeca-2,6,10-trienoate |
| fenbendazole | = methyl [5-(phenylsulfanyl)-1H-benzimidazol-2-yl]carbamate |
| L-firefly luciferin | = (R)-4,5-dihydro-2-(6-hydroxy-1,3-benzothiazol-2-yl)thiazole-4-carboxylate |
| D-firefly luciferin | = Photinus-luciferin |
| = (S)-4,5-dihydro-2-(6-hydroxy-1,3-benzothiazol-2-yl)thiazole-4-carboxylate |
| 12-epi-fischerindole G | = (6aR,8R,9S,10R,10aS)-8-chloro-9-ethenyl-10-isocyano-6,6,9-trimethyl-5,6,6a,7,8,9,10,10a-octahydroindeno[2,1-b]indole |
| 12-epi-fischerindole U | = (6aS,9S,10R,10aS)-9-ethenyl-10-isocyano-6,6,9-trimethyl-5,6,6a,7,8,9,10,10a-octahydroindeno[2,1-b]indole |
| 12-epi-fischerindole U | = (6aS,9S,10R,10aS)-9-ethenyl-10-isocyano-6,6,9-trimethyl-5H,6aH,7H,8H,10H,10aH-indeno[2,1-b]indole |
| flaviolin | = 2,5,7-trihydroxy-1,4-naphthoquinone |
| flaviolin | = 2,5,7-trihydroxynaphthalene-1,4-dione |
| flaviolin | = 4,5,7-trihydroxynaphthalene-1,2-dione |
| flavuxanthin | = 2,2′-bis-(4-hydroxy-3-methylbut-2-enyl)-1,16,1′,16′-tetradehydro-1,2,1′,2′-tetrahydro-ψ,ψ-carotene |
| = (2E,8E,10E,12E,14E,16E,18E,20E,22E,24E,26E,28E,34E)-5,32-diisopropenyl-2,8,12,16,21,25,29,35-octamethylhexatriaconta-2,8,10,12,14,16,18,20,22,24,26,28,34-tridecaene-1,36-diol |
| fraxetin | = 7,8-dihydroxy-6-methoxy-2H-chromen-2-one |
| fumagillin | = (2E,4E,6E,8E)-10-({(3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]oct-6-yl}oxy)-10-oxodeca-2,4,6,8-tetraenoate |
| fumagillol | = (3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-ol |
| fumigaclavine C | = 6,8β-dimethyl-2-(2-methylbut-3-en-2-yl)ergolin-9β-yl acetate |
| fumitremorgin B | = (5aR,6S,12S,14aS)-5a,6-dihydroxy-9-methoxy-11-(3-methylbut-2-en-1-yl)-12-(2-methylprop-1-en-1-yl)-1,2,3,5a,6,11,12,14a-octahydro-5H,14H-pyrrolo[1′′,2′′:4′,5′]pyrazino[1′,2′:1,6]pyrido[3,4-b]indole-5,14-dione |
| fumitremorgin C | = (5aS,12S,14aS)-9-methoxy-12-(2-methylprop-1-en-1-yl)-1,2,3,5a,6,11,12,14a-octahydro-5H,14H-pyrrolo[1′′,2′′:4′,5′]pyrazino[1′,2′:1,6]pyrido[3,4-b]indole-5,14-dione |
| fumonisin B1 | = (2R,2′R)-2,2′-{[(5R,6R,7S,9S,11R,16R,18S,19S)-19-amino-11,16,18-trihydroxy-5,9-dimethylicosane-6,7-diyl]bis[oxy(2-oxoethane-2,1-diyl)]}dibutanedioic acid |
| furaneol | = 4-hydroxy-2,5-dimethylfuran-3(2H)-one |
| futalosine | = 3-(3-((3S,4R)-3,4-dihydroxy-5-(6-oxo-3H-purin-9(6H)-yl)tetrahydrofuran-2-yl)propanoyl)benzoate |
| futalosine | = 3-{3-[(3S,4R)-3,4-dihydroxy-5-(6-oxo-1,6-dihydro-9H-purin-9-yl)tetrahydrofuran-2-yl]propanoyl}benzoate |
| Galp | = galactopyranose |
| galactarate | = (2R,3S,4R,5S)-2,3,4,5-tetrahydroxyhexanedioate |
| ganglioside GM2 | = 1-O-[O-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl-(1→4)-O-[N-acetyl-α-neuraminyl-(2→3)]-O-β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl]-ceramideganglioside GM3 |
| = 1-O-[O-(N-acetyl-α-neuraminyl)-(2→3)-O-β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl]-ceramideganglioside GD3 |
| = 1-O-[O-(N-acetyl-α-neuraminyl)-(2→8)-O-(N-acetyl-α-neuraminyl)-(2→3)-O-β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl]-ceramide ganglioside GD2 |
| GcvH | = glycine cleavage system H] |
| GDP | = guanosine 5′-diphosphate |
| β-geranylfarnesene | = (6E,10E,14E)-7,11,15,19-tetramethyl-3-methyleneicosa-1,6,10,14,18-pentaene |
| (+)-germacrene D | = (1E,6E,8R)-1-methyl-5-methylidene-8-(propan-2-yl)cyclodeca-1,6-diene |
| (-)-germacrene D | = (1E,6E,8S)-1-methyl-5-methylidene-8-(propan-2-yl)cyclodeca-1,6-diene |
| gibberellin A4 | = (1S,2S,4aR,4bR,7R,9aR,10S,10aR)-2-hydroxy-1-methyl-8-methylidene-13-oxododecahydro-4a,1-(epoxymethano)-7,9a-methanobenzo[a]azulene-10-carboxylic acid |
| gibberellin A9 | = (1R,4aR,4bR,7R,9aR,10S,10aR)-1-methyl-8-methylene-13-oxododecahydro-4a,1-(epoxymethano)-7,9a-methanobenzo[a]azulene-10-carboxylic acid |
| ginsenoside C-K | = (3β,12β)-3,12-dihydroxydammar-24-en-20-yl β-D-glucopyranoside |
| ginsenoside F1 | = (3β,6α,12β)-trihydroxydammar-24-en-20-yl β-D-glucopyranoside |
| ginsenoside F1 | = 20-(β-D-glucopyranosyloxy)dammar-24-en-3β,6α,12β-triol |
| ginsenoside F1 | = 3β,6α,12β-trihydroxydammar-24-en-20-yl β-D-glucopyranoside |
| ginsenoside F2 | = (3β,12β)-20-(β-D-glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl β-D-glucopyranoside |
| ginsenoside Rb1 | = 3β-[β-D-glucopyranosyl-(1→2)-β-D-glucopyranosyloxy]-20-[β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyloxy]dammar-24-en-12β-ol |
| ginsenoside Rb2 | = 3β-[β-D-glucopyranosyl-(1→2)-β-D glucopyranosyloxy]-20-[α-L-arabinopyranosyl-(1→6)-β-D glucopyranosyloxy]dammar-24-en-12β-ol |
| ginsenoside Rb3 | = 3β-[β-D-glucopyranosyl-(1→2)-β-D glucopyranosyloxy]-20-[β-D-xylopyranosyl-(1→6)-β-D glucopyranosyloxy]dammar-24-en-12β-ol |
| ginsenoside Rc | = 3β-[β-D-glucopyranosyl-(1→2)-β-D glucopyranosyloxy]-20-[α-L-arabinofuranosyl-(1→6)-β-D glucopyranosyloxy]dammar-24-en-12β-ol |
| ginsenoside Rd | = 20-(β-D-glucopyranosyl)oxy-3β-[β-D-glucopyranosyl-(1→2)-β-D-glucopyranosyloxy]dammar-24-en-12β-ol |
| ginsenoside Rd | = 3β-[β-D-glucopyranosyl-(1→2)-β-D-glucopyranosyloxy]-20-(β-D-glucopyranosyloxy)dammar-24-en-12β-ol |
| ginsenoside Re | = 20-(β-D-glucopyranosyl)oxy-6α-[α-L-rhamnopyranosyl-(1→2)-β-D-glucopyranosyloxy]dammar-24-en-3β,12β-diol |
| ginsenoside Rg1 | = 6α,20-bis(β-D-glucopyranosyl)oxy-dammar-24-en-3β,12β-diol |
| ginsenoside Rg3 | = 3β-[β-D-glucopyranosyl-(1→2)-β-D-glucopyranosyloxy]-20-(β-D-glucopyranosyloxy)dammar-24-ene-12β,20-diol |
| Glc2Man9GlcNAc2-[protein] | = [α-D-Glc-(1→3)-α-D-Glc-(1→3)-α-D-Man-(1→2)-α-D-Man-(1→2)-α-D-Man-(1→3)-{α-D-Man-(1→2)-α-D-Man-(1→3)-[α-D-Man-(1→2)-α-D-Man-(1→6)]-α-D-Man-(1→6)}-β-D-Man-(1→4)-β-D-GlcNAc-(1→4)-β-D-GlcNAc]-N-Asn-[protein] |
| Glc2Man9GlcNAc2-[protein] | = {α-D-Glc-(1→3)-α-D-Glc-(1→3)-α-D-Man-(1→2)-α-D-Man-(1→2)-α-D-Man-(1→3)-[α-D-Man-(1→2)-α-D-Man-(1→3)-[α-D-Man-(1→2)-α-D-Man-(1→6)]-α-D-Man-(1→6)]-β-D-Man-(1→4)-β-D-GlcNAc-(1→4)-β-D-GlcNAc}-N-Asn-[protein] |
| Glc3Man9GlcNAc2 | = [α-D-Glc-(1→2)-α-D-Glc-(1→3)-α-D-Glc-(1→3)-α-D-Man-(1→2)-α-D-Man-(1→2)-α-D-Man-(1→3)-{α-D-Man-(1→2)-α-D-Man-(1→3)-[α-D-Man-(1→2)-α-D-Man-(1→6)]-α-D-Man-(1→6)}-β-D-Man-(1→4)-β-D-GlcNAc-(1→4)-β-D-GlcNAc]-N-Asn-[protein] |
| GlcA | = glucuronic acid |
| GlcMan9GlcNAc2-[protein] | = {α-D-Glc-(1→3)-α-D-Man-(1→2)-α-D-Man-(1→2)-α-D-Man-(1→3)-[α-D-Man-(1→2)-α-D-Man-(1→3)-[α-D-Man-(1→2)-α-D-Man-(1→6)]-α-D-Man-(1→6)]-β-D-Man-(1→4)-β-D-GlcNAc-(1→4)-α-D-GlcNAc}-N-Asn-[protein] |
| GlcMan9GlcNAc2-[protein] | = {α-D-Glc-(1→3)-α-D-Man-(1→2)-α-D-Man-(1→2)-α-D-Man-(1→3)-[α-D-Man-(1→2)-α-D-Man-(1→3)-[α-D-Man-(1→2)-α-D-Man-(1→6)]-α-D-Man-(1→6)]-β-D-Man-(1→4)-β-D-GlcNAc-(1→4)-β-D-GlcNAc}-N-Asn-[protein] |
| GlcN | = D-glucosamine |
| = 2-amino-2-deoxy-D-glucopyranose |
| GlcNAc | = N-acetyl-D-glucosamine |
| glucotropaeolin | = 1-S-[(1Z)-2-phenyl-N-(sulfonatooxy)ethanimidoyl]-1-thio-β-D-glucopyranose |
| γ-L-glutamyl-butirosin B | = (1R,2R,3S,4R,6S)-6-amino-4-{[(2R)-4-(γ-L-glutamylamino)-2-hydroxybutanoyl]amino}-3-hydroxy-2-(α-D-ribofuranosyloxy)cyclohexyl |
| glycocholate | = N-(3α,7α,12α-trihydroxy-5β-cholan-24-oyl)glycine |
| glycyrrhetinate | = 3-β-glycyrrhetinate |
| = 3β-hydroxy-11-oxoolean-12-en-30-oate |
| GMP | = guanosine 5′-phosphate |
| gramine | = (1H-indol-3-ylmethyl)dimethylamine |
| = (1H-indol-3-yl)-N,N-dimethylmethanamine |
| grixazone B | = 8-amino-9-(N-acetyl-L-cystein-S-yl)-7-oxo-7H-phenoxazine-2-carboxylic acid |
| (1R,4R,5S)-(–)-guaia-6,10(14)-diene | = (1R)-1-methyl-4-methylidene-7-(propan-2-yl)-1,2,3,3a,4,5,6,8a-octahydroazulene |
| = (1R)-7-isopropyl-1-methyl-4-methylene-1,2,3,3a,4,5,6,8a-octahydroazulene |
| gypenoside LXXV | = 20-[β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyloxy]dammar-24-ene-3β,12β-diol |
| gypenoside XVII | = 3β-(β-D-glucopyranosyloxy)-20-[β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyloxy]dammar-24-en-12β-ol |
| hapalindole H | = (6aR,9R,10R,10aR)-9-ethenyl-1-isocyano-6,6,9-trimethyl-2,6,6a,7,8,9,10,10a-decahydronaphtho[1,2,3-cd]indole |
| 12-epi-hapalindole H | = (6aR,9S,10R,10aR)-9-ethenyl-1-isocyano-6,6,9-trimethyl-2,6,6a,7,8,9,10,10a-decahydronaphtho[1,2,3-cd]indole |
| Hep | = L-glycero-β-D-manno-heptose |
| Hep | = L-glycero-D-manno-heptose |
| hepoxilin A3 | = (5Z,9E,14Z)-(8ξ,11R,12S)-11,12-epoxy-8-hydroxyicosa-5,9,14-trienoate |
| hepta-acyl lipid A | = 2-deoxy-2-[(3R)-3-(tetradecanoyloxy)tetradecanamido]-3-O-[(3R)-3-(dodecanoyloxy)tetradecanoyl]-4-O-phospho-β-D-glucopyranosyl-(1→6)-2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-[(3R)-3-(hexadecanoyloxy)tetradecanamido]-α-D-glucopyranosyl phosphate |
| hercynine | = Nα,Nα,Nα-trimethyl-L-histidine |
| = 3-(1H-imidazol-5-yl)-2-(trimethylamino)propanoate |
| hesperetin | = 5,7,3′-trihydroxy-4′-methoxyflavanone |
| hesperidin | = hesperetin 7-(6-O-α-L-rhamnopyranosyl-β-D-glucopyranoside) |
| hexa-acyl lipid A | = 2-deoxy-2-[(3R)-3-(tetradecanoyloxy)tetradecanamido]-3-O-[(3R)-3-(dodecanoyloxy)tetradecanoyl]-4-O-phospho-β-D-glucopyranosyl-(1→6)-2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-[(3R)-3-hydroxytetradecanamido]-α-D-glucopyranosyl phosphate |
| (9Z)-hexadec-9-enoyl-Kdo2-lipid IVA | = α-Kdo-(2→4)-α-Kdo-(2→6)-2-deoxy-2-{(3R)-3-[(9Z)-hexadec-9-enoyl]tetradecanamido}-3-O-[(3R)-3-hydroxytetradecanoyl]-4-O-phospho-β-D-glucopyranosyl-(1→6)-2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-[(3R)-3-hydroxytetradecanamido]-α-D-glucopyranosyl phosphate |
| homoisocitrate | = (–)-threo-homoisocitrate |
| = (1R,2S)-1-hydroxybutane-1,2,4-tricarboxylate |
| homoisocitrate | = (-)-threo-homoisocitrate |
| = (1R,2S)-1-hydroxybutane-1,2,4-tricarboxylate |
| (8R)-HPETE | = (5Z,8R,9E,11Z,14Z)-8-hydroperoxyicosa-5,9,11,14-tetraenoate |
| (8S)-HPETE | = (5Z,8S,9E,11Z,14Z)-8-hydroperoxyicosa-5,9,11,14-tetraenoate |
| (12R)-HPETE | = (5Z,8Z,10E,12R,14Z)-12-hydroperoxyicosa-5,8,10,14-tetraenoate |
| (12S)-HPETE | = (5Z,8Z,10E,12S,14Z)-12-hydroperoxyicosa-5,8,10,14-tetraenoate |
| (15R)-HPETE | = (5Z,8Z,11Z,13E,15R)-15-hydroperoxyicosa-5,8,11,13-tetraenoate |
| hydropyrene | = (1R,3aR,3a1R,5aR,5a1S,8aS,10aS)-1,5a,8a-trimethyl-4-methylidenehexadecahydropyrene |
| hydropyrenol | = (1R,3aR,3a1S,4S,5aR,5a1S,8aS,10aS)-1,4,5a,8a-tetramethylhexadecahydropyren-4-ol |
| 2-hydroxy-1a-methyl-7a-[(2E,6E)-farnesyl]-1a,2-dihydrooxireno[2,3-b]quinolin-7(7aH)-one | = 2-hydroxy-1a-methyl-7a-((2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl)-1a,2-dihydrooxireno[2,3-b]quinolin-7(7aH)-one |
| 3α-hydroxy-3,5-dihydromonacolin L | = (3R,5R)-7-[(1R,2R,3S,6R,8aR)-3-hydroxy-2,6-dimethyl-1,2,3,5,6,7,8,8a-octahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate |
| (3S)-3-hydroxy-L-enduracididine | = (2S,3R)-2-amino-3-hydroxy-3-[(S)-2-iminoimidazolidin-4-yl]propanoic acid |
| = (3R)-3-[(4S)-2-iminoimidazolidin-4-yl]-L-serine |
| 5-hydroxyectoine | = (4S,5S)-5-hydroxy-2-methyl-1,4,5,6-tetrahydropyrimidine-4-carboxylate |
| hydroxysqualene | = (6E,10E,12R,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-12-ol |
| 6-hydroxytryprostatin B | = (3S,8aS)-3-{[6-hydroxy-2-(3-methylbut-2-en-1-yl)-1H-indol-3-yl]methyl}hexahydropyrrolo[1,2-a]pyrazine-1,4-dione |
| hypusine | = N6-[(R)-4-amino-2-hydroxybutyl]-L-lysine |
| ibotenate | = (S)-2-amino-2-(3-hydroxyisoxazol-5-yl)acetate |
| idarubicin | = (7S,9S)-9-acetyl-7-(3-amino-2,3,6-trideoxy-β-L-lyxo-hexosyloxy)-6,9,11-trihydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione |
| IMP | = inosine 5′-phosphate |
| (indol-3-yl)pyruvate | = 3-(1H-indol-3-yl)-2-oxopropanoate, (indol-3-yl)acetate |
| = 2-(1H-indol-3-yl)acetate |
| = indole-3-acetate |
| indolmycin | = (5S)-5-[(1R)-1-(indol-3-yl)ethyl]-2-(methylamino)-1,3-oxazolin-4(5H)-one |
| inunolide | = germacra-1(10),4,11(13)-trien-12,8β-lactone |
| β-ionone | = (3E)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-3-en-2-one |
| ipsdienol | = 2-methyl-6-methyleneocta-2,7-dien-4-ol |
| ipsdienone | = 2-methyl-6-methyleneocta-2,7-dien-4-one |
| (+)-isoafricanol | = (1aS,4aR,5R,7aS,7bR)-3,3,5,7b-tetramethyldecahydro-4aH-cyclopropa[e]azulen-4a-ol |
| isochorismate | = (5S,6S)-5-[(1-carboxyethenyl)oxy]-6-hydroxycyclohexa-1,3-diene-1-carboxylate |
| isocitrate | = (1R,2S)-1-hydroxypropane-1,2,3-tricarboxylate (previously known as threo-Ds-isocitrate) |
| isocitrate | = (1R,2S)-1-hydroxypropane-1,2,3-tricarboxylate |
| = threo-Ds-isocitrate |
| (-)-α-isocomene | = (1R,3aS,5aS,8aR)-1,3a,4,5a-tetramethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene |
| isoelisabethatriene | = (1S,4R)-4,7-dimethyl-1-[(2R)-6-methylhept-5-en-2-yl]-1,2,3,4,5,6-hexahydronaphthalene |
| isoflavan | = isoflavonoid with a 3,4-dihydro-3-aryl-2H-1-benzopyran skeleton. |
| isonocardicin C | = (2S)-2-amino-4-{4-[(R)-amino({[(3S)-1-[(R)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl})methyl]phenoxy}butanoic acid |
| isopyridoxal | = 5-hydroxy-4-(hydroxymethyl)-6-methylpyridine-3-carbaldehyde |
| isourate | = 1,3,5,7-tetrahydropurine-2,6,8-trione |
| (+)-epi-isozizaene | = (3S,3aR,6S)-3,7,7,8-tetramethyl-2,3,4,5,6,7-hexahydro-1H-3a,6-methanoazulene |
| (–)-jasmonate | = {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetate |
| jasmonic acid | = {(1R,2R)-3-oxo-2-[(2Z)pent-2-en-1-yl]cyclopentyl}acetic acid |
| jasmonic acid | = {(1R,2R)-3-oxo-2-[(Z)pent-2-enyl]cyclopent-2-enyl}acetic acid |
| juglone | = 5-hydroxy-1,4-naphthoquinone |
| juvenile hormone I | = methyl (2E,6E,10R,11S)-10,11-epoxy-7-ethyl-3,11-dimethyl-2,6-tridecadienoate |
| kanamycin A | = (1S,2R,3R,4S,6R)-4,6-diamino-3-(6-amino-6-deoxy-α-D-glucopyranosyloxy)-2-hydroxycyclohexyl 3-amino-3-deoxy-α-D-glucopyranoside |
| kanamycin A | = (1S,2R,3R,4S,6R)-4,6-diamino-3-(6-amino-6-deoxy--D-glucopyranosyloxy)-2-hydroxycyclohexyl 3-amino-3-deoxy--D-glucopyranoside |
| kanamycin B | = (1R,2S,3S,4R,6S)-4,6-diamino-3-(3-amino-3-deoxy-α-D-glucopyranosyloxy)-2-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-α-D-glucopyranoside |
| kanamycin C | = (1R,2S,3S,4R,6S)-4,6-diamino-3-(3-amino-3-deoxy-α-D-glucopyranosyloxy)-2-hydroxycyclohexyl 2-amino-2-deoxy-α-D-glucopyranoside |
| kanamycin X | = (1S,2R,3R,4S,6R)-4,6-diamino-3-(α-D-glucopyranosyloxy)-2-hydroxycyclohexyl 3-amino-3-deoxy-α-D-glucopyranoside |
| Kdo | = 3-deoxy-D-manno-oct-2-ulopyranosylonic acid |
| (Kdo)-lipid IVA | = α-Kdo-(2→6)-lipid IVA |
| = (3-deoxy-α-D-manno-oct-2-ulopyranosylonate)-(2→6)-2-deoxy-2-{[(3R)-3-hydroxytetradecanoyl]amino}-3-O-[(3R)-3-hydroxytetradecanoyl]-4-O-phosphono-β-D-glucopyranosyl-(1→6)-2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-{[(3R)-3-hydroxytetradecanoyl]amino}-1-O-phosphono-α-D-glucopyranose |
| (Kdo)2-lipid IVA | = α-Kdo-(2→4)-α-Kdo-(2→6)-lipid IVA |
| = (3-deoxy-α-D-manno-oct-2-ulopyranosylonate)-(2→4)-(3-deoxy-α-D-manno-oct-2-ulopyranosylonate)-(2→6)-2-deoxy-2-{[(3R)-3-hydroxytetradecanoyl]amino}-3-O-[(3R)-3-hydroxytetradecanoyl]-4-O-phosphono-β-D-glucopyranosyl-(1→6)-2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-{[(3R)-3-hydroxytetradecanoyl]amino}-1-O-phosphono-α-D-glucopyranose |
| (Kdo)3-lipid IVA | = α-Kdo-(2→8)-α-Kdo-(2→4)-α-Kdo-(2→6)-lipid IVA |
| = (3-deoxy-α-D-manno-oct-2-ulopyranosylonate)-(2→8)-(3-deoxy-α-D-manno-oct-2-ulopyranosylonate)-(2→4)-(3-deoxy-α-D-manno-oct-2-ulopyranosylonate)-(2→6)-2-deoxy-2-{[(3R)-3-hydroxytetradecanoyl]amino}-3-O-[(3R)-3-hydroxytetradecanoyl]-4-O-phosphono-β-D-glucopyranosyl-(1→6)-2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-{[(3R)-3-hydroxytetradecanoyl]amino}-1-O-phosphono-α-D-glucopyranose |
| (Kdo)4-lipid IVA | = α-Kdo-(2→8)-[α-Kdo-(2→4)]-α-Kdo-(2→4)-α-Kdo-(2→6)-lipid IVA |
| = (3-deoxy-α-D-manno-oct-2-ulopyranosylonate)-(2→8)-[(3-deoxy-α-D-manno-oct-2-ulopyranosylonate)-(2→4)]-(3-deoxy-α-D-manno-oct-2-ulopyranosylonate)-(2→4)-(3-deoxy-α-D-manno-oct-2-ulopyranosylonate)-(2→6)-2-deoxy-2-{[(3R)-3-hydroxytetradecanoyl]amino}-3-O-[(3R)-3-hydroxytetradecanoyl]-4-O-phosphono-β-D-glucopyranosyl-(1→6)-2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-{[(3R)-3-hydroxytetradecanoyl]amino}-1-O-phosphono-α-D-glucopyranose |
| α-Kdo-(2→4)-α-Kdo-(2→6)-(acyl)-[lipid IVA] | = 3-deoxy-α-D-manno-oct-2-ulopyranosyl-(2→4)-3-deoxy-α-D-manno-oct-2-ulopyranosyl-(2→6)-2-deoxy-2-{[(3R)-3-(acyloxy)acyl]amino}-3-O-[(3R)-3-hydroxyacyl]-4-O-phospho-β-D-glucopyranosyl-(1→6)-2-deoxy-3-O-[(3R)-3-hydroxyacyl]-2-{[(3R)-3-hydroxyacyl]amino}-1-O-phosphono-α-D-glucopyranose |
| α-Kdo-(2→4)-α-Kdo-(2→6)-(acyl)2-[lipid IVA] | = 3-deoxy-α-D-manno-oct-2-ulopyranosyl-(2→4)-3-deoxy-α-D-manno-oct-2-ulopyranosyl-(2→6)-2-deoxy-2-{[(3R)-3-(acyloxy)acyl]amino}-3-O-[(3R)-3-(acyloxy)acyl]-4-O-phospho-β-D-glucopyranosyl-(1→6)-2-deoxy-3-O-[(3R)-3-hydroxyacyl]-2-{[(3R)-3-hydroxyacyl]amino}-1-O-phospho-α-D-glucopyranose |
| α-Kdo-(2→4)-α-Kdo-(2→6)-[4′-P-α-L-Ara4N]-lipid A | = (3-deoxy-α-D-manno-oct-2-ulopyranosylonate)-(2→4)-(3-deoxy-α-D-manno-oct-2-ulopyranosylonate)-(2→6)-2-deoxy-2-{[(3R)-3-(dodecanoyloxy)tetradecanoyl]amino}-3-O-[(3R)-3-(tetradecanoyloxy)tetradecanoyl]-4-O-(4-amino-4-deoxy-α-L-arabinopyranosyl)phospho-β-D-glucopyranosyl-(1→6)-2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-{[(3R)-3-hydroxytetradecanoyl]amino}-1-O-phosphono-α-D-glucopyranose |
| α-Kdo-(2→4)-α-Kdo-(2→6)-lipid A | = (3-deoxy-α-D-manno-oct-2-ulopyranosylonate)-(2→4)-(3-deoxy-α-D-manno-oct-2-ulopyranosylonate)-(2→6)-2-deoxy-2-{[(3R)-3-(dodecanoyloxy)tetradecanoyl]amino}-3-O-[(3R)-3-(tetradecanoyloxy)tetradecanoyl]-4-O-phospho-β-D-glucopyranosyl-(1→6)-2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-{[(3R)-3-hydroxytetradecanoyl]amino}-1-O-phosphono-α-D-glucopyranose |
| α-Kdo-(2→4)-α-Kdo-(2→6)-lipid IVA | = (3-deoxy-α-D-manno-oct-2-ulopyranosylonate)-(2→4)-(3-deoxy-α-D-manno-oct-2-ulopyranosylonate)-(2→6)-2-deoxy-2-{[(3R)-3-hydroxytetradecanoyl]amino}-3-O-[(3R)-3-hydroxytetradecanoyl]-4-O-phosphono-β-D-glucopyranosyl-(1→6)-2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-{[(3R)-3-hydroxytetradecanoyl]amino}-1-O-phosphono-α-D-glucopyranose |
| 12-KETE | = 12-oxo-ETE |
| = (5Z,8Z,10E,14Z)-12-oxoicosa-5,8,10,14-tetraenoate |
| kojibiose | = α-D-glucopyranosyl-(1→2)-D-glucopyranose |
| (+)-kolavelool | = (2ξ)-3-methyl-5-[(1R,2S,4aS,8aS)-1,2,4a,5-tetramethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl]pent-1-en-3-ol |
| (+) kolavenyl diphosphate | = (2E)-3-methyl-5-[(1R,2S,4aS,8aS)-1,2,4a,5-tetramethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl]pent-2-en-1-yl diphosphate |
| (–)-kolavenyl diphosphate | = (2E)-5-[(1R,2S,4aS,8aS)-1,2,4a,5-tetramethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl]-3-methylpent-2-en-1-yl diposphate |
| kunzeaol | = 6β-hydroxygermacra-1(10),4-diene |
| = (1R,2E,6E,10R)-3,7-dimethyl-10-isopropylcyclodeca-2,6-dienol |
| kynurenine | = 2-amino-4-(2-aminophenyl)-4-oxobutanoic acid |
| = 3-anthraniloylalanine |
| lactose | = β-D-galactopyranosyl-(1→4)-α-D-glucopyranose |
| lactotriosylceramide | = N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-ceramide |
| lanosterol | = 4,4,14-trimethyl-5α-cholesta-8,24-dien-3β-ol |
| (–)-lariciresinol | = 4-[(2R,3S,4S)-4-[(4-hydroxy-3-methoxyphenyl)methyl]-3-(hydroxymethyl)oxolan-2-yl]-2-methoxyphenol |
| (+)-lariciresinol | = 4-[(2S,3R,4R)-4-[(4-hydroxy-3-methoxyphenyl)methyl]-3-(hydroxymethyl)oxolan-2-yl]-2-methoxyphenol |
| (+)-larreatricin | = 4,4′-[(2R,3R,4S,5R)-3,4-dimethyltetrahydrofuran-2,5-diyl]bisphenol |
| (R)-laudanine | = 5-[((1R)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl]-2-methoxyphenol |
| (S)-laudanine | = 5-[((1S)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl]-2-methoxyphenol |
| lavandulyl | = 5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl |
| leachianone G | = (–)-(2S)-2′-hydroxy-8-prenylnaringenin |
| = (–)-(2S)-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-4H-chromen-4-one |
| legionaminate | = 5,7-diamino-3,5,7,9-tetradeoxy-D-glycero-D-galacto-non-2-ulosonate |
| leukotriene A4 | = (7E,9E,11Z,14Z)-(5S,6S)-5,6-epoxyicosa-7,9,11,14-tetraenoate |
| leukotriene B4 | = (6Z,8E,10E,14Z)-(5S,12R)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate |
| leukotriene C4 | = (7E,9E,11Z,14Z)-(5S,6R)-6-(glutathion-S-yl)-5-hydroxyicosa-7,9,11,14-tetraenoate |
| ligstroside | = methyl (2S,3E,4S)-3-ethylidene-2-(β-D-glucopyranosyloxy)-4-{2-[2-(4-hydroxyphenyl)ethoxy]-2-oxoethyl}-3,4-dihydro-2H-pyran-5-carboxylate |
| (+)-limonene | = (R)-limonene |
| = (4R)-1-methyl-4-(prop-1-en-2-yl)cyclohexene |
| (–)-limonene | = (S)-limonene |
| = (4S)-1-methyl-4-(prop-1-en-2-yl)cyclohexene |
| limonene | = 1-methyl-4-(prop-1-en-2-yl)cyclohex-1-ene |
| limonene-1,2-diol | = menth-8-ene-1,2-diol |
| = 1-methyl-4-(prop-1-en-2-yl)cyclohexane-1,2-diol |
| linalool | = 3,7-dimethylocta-1,6-dien-3-ol |
| 3-linalylflaviolin | = 2,5,7-trihydroxy-3-(3,7-dimethylocta-1,6-dien-3-yl)naphthalene-1,4-dione |
| linoleoyl-CoA | = cis,cis-octadeca-9,12-dienoyl-CoA |
| = (9Z,12Z)-octadeca-9,12-dienoyl-CoA |
| = 18:2(n-6) |
| lipid A (Campylobacter jejuni) | = 2,3-dideoxy-2,3-bis[(3R)-3-(hexadecanoyloxy)tetradecanamido]-4-O-phospho-β-D-glucopyranosyl-(1→6)-2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-[(3R)-3-hydroxytetradecanamido]-α-D-glucopyranosyl phosphate |
| lipid A (Helicobacter pylori) | = 2-deoxy-2-[(3R)-3-(octadecanoyloxy)octadecanamido]-4-O-phospho-β-D-glucopyranosyl-(1→6)-2-deoxy-3-O-[(3R)-3-hydroxyhexadecanoyl]-2-[(3R)-3-hydroxyoctadecanamido]-α-D-glucopyranosyl phosphate |
| lipid A | = 2-deoxy-2-[(3R)-3-(tetradecanoyloxy)tetradecanamido]-3-O-[(3R)-3-(dodecanoyloxy)tetradecanoyl]-4-O-phospho-β-D-glucopyranosyl-(1→6)-2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-[(3R)-3-hydroxytetradecanamido]-α-D-glucopyranosyl phosphate |
| lipid A | = lipid A of Escherichia coli |
| = 2-deoxy-2-{[(3R)-3-(dodecanoyloxy)tetradecanoyl]amino}-3-O-[(3R)-3-(tetradecanoyloxy)tetradecanoyl]-4-O-phospho-β-D-glucopyranosyl-(1→6)-2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-{[(3R)-3-hydroxytetradecanoyl]amino}-1-O-phosphono-α-D-glucopyranose |
| lipid A disaccharide | = 2-deoxy-2-{[(3R)-3-hydroxyacyl]amino}-3-O-[(3R)-3-hydroxyacyl]-β-D-glucopyranosyl-(1→6)-2-deoxy-3-O-[(3R)-3-hydroxyacyl]-2-{[(3R)-3-hydroxyacyl]amino}-1-O-phospho-α-D-glucopyranose |
| lipid A disaccharide | = dephospho-lipid IVA |
| = 2-deoxy-2-{[(3R)-3-hydroxyacyl]amino}-3-O-[(3R)-3-hydroxyacyl]-β-D-glucopyranosyl-(1→6)-2-deoxy-3-O-[(3R)-3-hydroxyacyl]-2-{[(3R)-3-hydroxyacyl]amino}-1-O-phospho-α-D-glucopyranose |
| lipid II | = undecaprenyldiphospho-N-acetyl-(N-acetylglucosaminyl)muramoyl peptide; the peptide element refers to L-alanyl-D-γ-glutamyl-L-lysyl/meso-2,6-diaminopimelyl-D-alanyl-D-alanine or a modified version thereof |
| = undecaprenyldiphospho-4-O-(N-acetyl-β-D-glucosaminyl)-3-O-peptidyl-α-N-acetylmuramate; the peptide element refers to L-alanyl-D-γ-glutamyl-L-lysyl/meso-2,6-diaminopimelyl-D-alanyl-D-alanine or a modified version thereof |
| lipid IIA | = 4-amino-4-deoxy-β-L-arabinopyranosyl 2-deoxy-2-[(3R)-3-hydroxytetradecanamido]-3-O-[(3R)-3-hydroxytetradecanoyl]-4-O-phospho-β-D-glucopyranosyl-(1→6)-2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-[(3R)-3-hydroxytetradecanamido]-α-D-glucopyranose phosphate |
| lipid IIA | = 4-amino-4-deoxy-β-L-arabinopyranosyl 2-deoxy-2-{[(3R)-3-hydroxytetradecanoyl]amino}-3-O-[(3R)-3-hydroxytetradecanoyl]-4-O-phospho-β-D-glucopyranosyl-(1→6)-2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-{[(3R)-3-hydroxytetradecanoyl]amino}-α-D-glucopyranosyl phosphate |
| lipid IIB | = 4-amino-4-deoxy-β-L-arabinopyranosyl 2-deoxy-2-[(3R)-3-hydroxytetradecanamido]-3-O-[(3R)-3-hydroxytetradecanoyl]-4-O-phospho-β-D-glucopyranosyl-(1→6)-2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-[(3R)-3-(hexadecanoyloxy)tetradecanamido]-α-D-glucopyranosyl phosphate |
| lipid III | = N-acetyl-β-D-fucosyl-(1→4)-N-acetyl-β-D-mannosaminouronyl-(1→4)-N-acetyl-α-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol |
| lipid IVA | = 2-deoxy-2-[(3R)-3-hydroxytetradecanamido]-3-O-[(3R)-3-hydroxytetradecanoyl]-4-O-phospho-β-D-glucopyranosyl-(1→6)-2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-[(3R)-3-hydroxytetradecanamido]-α-D-glucopyranose phosphate |
| lipid IVA | = 2-deoxy-2-[(3R)-3-hydroxytetradecanamido]-3-O-[(3R)-3-hydroxytetradecanoyl]-4-O-phospho-β-D-glucopyranosyl-(1→6)-2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-[(3R)-3-hydroxytetradecanamido]-α-D-glucopyranosyl phosphate |
| lipid IVA | = 2-deoxy-2-{[(3R)-3-hydroxyacyl]amino}-3-O-[(3R)-3-hydroxyacyl]-4-O-phospho-β-D-glucopyranosyl-(1→6)-2-deoxy-3-O-[(3R)-3-hydroxyacyl]-2-{[(3R)-3-hydroxyacyl]amino}-1-O-phospho-α-D-glucopyranose |
| lipid IVA | = 2-deoxy-2-{[(3R)-3-hydroxytetradecanoyl]amino}-3-O-[(3R)-3-hydroxytetradecanoyl]-4-O-phospho-β-D-glucopyranosyl-(1→6)-2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-{[(3R)-3-hydroxytetradecanoyl]amino}-1-O-phosphono-α-D-glucopyranose |
| lipid IVB | = 2-deoxy-2-[(3R)-3-hydroxytetradecanamido]-3-O-[(3R)-3-hydroxytetradecanoyl]-4-O-phospho-β-D-glucopyranosyl-(1→6)-2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-[(3R)-3-(hexadecanoyloxy)tetradecanamido]-α-D-glucopyranosyl phosphate |
| lipid X | = 2-N-[(3R)-3-hydroxyacyl]-3-O-[(3R)-3-hydroxyacyl]-α-D-glucosamine 1-phosphate = |
| lipoic acid | = 5-[(3R)-1,2-dithiolan-3-yl]pentanoic acid |
| logonate | = (1S,4aS,6S,7R,7aS)-1-(β-D-glucopyranosyloxy)-6-hydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylate |
| long-chain alcohol | = alcohol derived from a fatty acid with an aliphatic chain of 13-22 carbons. |
| long-chain aldehyde | = aldehyde derived from a fatty acid with an aliphatic chain of 13-22 carbons. |
| lophenol | = 4α-methyl-5α-cholesta-7-en-3β-ol |
| lovastatin acid | = (3R,5R)-7-[(1S,2S,6R,8S,8aR)-2,6-dimethyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate |
| Cypridina-luciferin | = (3-{3,7-dihydro-6-(1H-indol-3-yl)-2-[(S)-1-methylpropyl]-3-oxoimidazo[1,2-a]pyrazin-8-yl}propyl)guanidine |
| Latia-luciferin | = (E)-2-methyl-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-1-en-1-yl formate |
| Oplophorus luciferin | = 8-benzyl-2-(4-hydroxybenzyl)-6-(4-hydroxyphenyl)imidazo[1,2-a]pyrazin-3(7H)-one |
| lutein | = (3R,3′R)-dihydroxy-α-carotene |
| luteone | = 3-(2,4-dihydroxyphenyl)-5,7-dihydroxy-6-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one |
| luteothin | = 2-[(3E,5E)-3,5-dimethyl-6-(4-nitrophenyl)hexa-3,5-dien-1-yl]-6-methoxy-3,5-dimethyl-4H-pyran-4-one |
| lycopaoctaene | = 15,15′-dihydrophytoene |
| = (6E,10E,14E,18E,22E,26E)-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,10,14,18,22,26,30-octaene |
| lydicene | = (4aR,6aS)-2,2,4α,6α,9-pentamethyl-1,3,4,5,6,7,10,11-octahydro-1H-cyclohepta[a]naphthalene |
| lysidine | = N6-(4-amino-1-β-D-ribofuranosylpyrimidin-2-ylidene)-L-lysine |
| L-lyxonate | = (2R,3R,4S)-2,3,4,5-tetrahydroxypentanoate |
| (–)-maackiain | = (6aR,12aR)-6a,12a-dihydro-6H-[1,3]dioxolo[5,6][1]benzofuro[3,2-c]chromen-3-ol |
| (+)-maackiain | = (6aS,12aS)-6a,12a-dihydro-6H-[1,3]dioxolo[5,6][1]benzofuro[3,2-c]chromen-3-ol |
| (S)-magnoflorine | = (6aS)-1,11-dihydroxy-2,10-dimethoxy-6,6-dimethyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinolinium |
| maltose | = α-D-glucopyranosyl-(1→4)-D-glucose |
| Man3GlcNAc3-[protein] | = {β-D-GlcNAc-(1→2)-α-D-Man-(1→3)-[α-D-Man-(1→6)]-β-D-Man-(1→4)-β-D-GlcNAc-(1→4)-β-D-GlcNAc}-N-Asn-[protein] |
| Man5GlcNAc2-[protein] | = α-D-Man-(1→3)-[α-D-Man-(1→3)-[α-D-Man-(1→6)]-α-D-Man-(1→6)]-β-D-Man-(1→4)-β-D-GlcNAc-(1→4)-α-D-GlcNAc-N-Asn-[protein] |
| Man5GlcNAc2-[protein] | = [α-D-Man-(1→3)-{α-D-Man-(1→3)-[α-D-Man-(1→6)]-α-D-Man-(1→6)}-β-D-Man-(1→4)-β-D-GlcNAc-(1→4)-β-D-GlcNAc]-N-Asn-[protein] |
| Man5GlcNAc3-[protein] | = [β-D-GlcNAc-(1→2)-α-D-Man-(1→3)-{α-D-Man-(1→3)-[α-D-Man-(1→6)]-α-D-Man-(1→6)}-β-D-Man-(1→4)-β-D-GlcNAc-(1→4)-β-D-GlcNAc]-N-Asn-[protein] |
| Man7GlcNAc2-[protein] (isomer 7A1,2,3B3) | = {α-D-Man-(1→2)-α-D-Man-(1→2)-α-D-Man-(1→3)-[α-D-Man-(1→2)-α-D-Man-(1→3)-[α-D-Man-(1→6)]-α-D-Man-(1→6)]-β-D-Man-(1→4)-β-D-GlcNAc-(1→4)-α-D-GlcNAc}-N-Asn-[protein] |
| Man9GlcNAc2-[protein] | = [α-D-Man-(1→2)-α-D-Man-(1→2)-α-D-Man-(1→3)-{α-D-Man-(1→2)-α-D-Man-(1→3)-[α-D-Man-(1→2)-α-D-Man-(1→6)]-α-D-Man-(1→6)}-β-D-Man-(1→4)-β-D-GlcNAc-(1→4)-β-D-GlcNAc]-N-Asn-[protein] |
| Man9GlcNAc2-[protein] | = {α-D-Man-(1→2)-α-D-Man-(1→2)-α-D-Man-(1→3)-[α-D-Man-(1→2)-α-D-Man-(1→3)-[α-D-Man-(1→2)-α-D-Man-(1→6)]-α-D-Man-(1→6)]-β-D-Man-(1→4)-β-D-GlcNAc-(1→4)-α-D-GlcNAc}-N-Asn-[protein] |
| Man9GlcNAc2-[protein] | = {α-D-Man-(1→2)-α-D-Man-(1→2)-α-D-Man-(1→3)-[α-D-Man-(1→2)-α-D-Man-(1→3)-[α-D-Man-(1→2)-α-D-Man-(1→6)]-α-D-Man-(1→6)]-β-D-Man-(1→4)-β-D-GlcNAc-(1→4)-β-D-GlcNAc}-N-Asn-[protein] |
| maniladiol | = 16β-hydroxy-β-amyrin |
| = olean-12-ene-3β,16β-diol |
| mannuronan | = linear polymer of β-D-mannuronate residues linked by (1-4) linkages |
| (+)-marmesin | = (S)-2-(2-hydroxypropan-2-yl)-2,3-dihydro-7H-furo[3,2-g]chromen-7-one |
| (–)-matairesinol | = 3R,4R)-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one |
| (–)-medicarpin | = (6aR,11aR)-9-methoxy-6a,11a-dihydro-6H-[1]benzofuro[3,2-c]chromen-3-ol |
| (+)-medicarpin | = (6aS,11aS)-9-methoxy-6a,11a-dihydro-6H-[1]benzofuro[3,2-c]chromen-3-ol |
| melamine | = 2,4,6-triamino-1,3,5-triazine |
| methanophenazine | = 2-{[(6E,10E,14E)-3,7,11,15,19-pentamethylicosa-6,10,14,18-tetraen-1-yl]oxy}phenazine |
| methyl aklanonate | = methyl [1,4,5-trihydroxy-9,10-dioxo-3-(3-oxopentanoyl)-9,10-dihydroanthracen-2-yl]acetate |
| methyl aklanonate | = methyl [4,5-dihydroxy-9,10-dioxo-3-(3-oxopentanoyl)-9,10-dihydroanthracen-2-yl]acetate |
| methyl gibberellin A4 | = methyl (1S,2S,4aR,4bR,7R,9aR,10S,10aR)-2-hydroxy-1-methyl-8-methylene-13-oxododecahydro-4a,1-(epoxymethano)-7,9a-methanobenzo[a]azulene-10-carboxylate |
| methyl gibberellin A9 | = methyl (1R,4aR,4bR,7R,9aR,10S,10aR)-1-methyl-8-methylene-13-oxododecahydro-4a,1-(epoxymethano)-7,9a-methanobenzo[a]azulene-10-carboxylate |
| methyl nogalonate | = methyl [4,5-dihydroxy-9,10-dioxo-3-(3-oxobutanoyl)-9,10-dihydroanthracen-2-yl]acetate |
| microthecin | = 2-hydroxy-2-(hydroxymethyl)-2H-pyran-3(6H)-one |
| L-mimosine | = (2S)-2-amino-3-(3-hydroxy-4-oxopyridin-1(4H)-yl)propanoic acid |
| L-mimosine | = (2S)-2-amino-3-[3-hydroxy-4-oxopyridin-1(4H)-yl]propanoate |
| mitomycin A | = [(1aS,8S,8aR,8bS)-5-methyl-6,8a-dimethoxy-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazirino[2′,3′:3,4]pyrrolo[1,2-a]indol-8-yl]methyl carbamate |
| mitomycin B | = [(1aS,8S,8aR,8bS)-8a-hydroxy-5-methyl-6-methoxy-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazirino[2′,3′:3,4]pyrrolo[1,2-a]indol-8-yl]methyl carbamate |
| mogrol | = (23R)-cucurbit-5-ene-3β,11α,23,25-tetraol |
| molybdenum cofactor | = MoCo |
| = MoO2(OH)Dtpp-mP |
| = {[(5aR,8R,9aR)-2-amino-4-oxo-6,7-bis(sulfanyl-κS)-1,5,5a,8,9a,10-hexahydro-4H-pyrano[3,2-g]pteridin-8-yl]methyl dihydrogenato(2-) phosphate}(dioxo)molybdate |
| molybdopterin | = H2Dtpp-mP |
| = [(5aR,8R,9aR)-2-amino-4-oxo-6,7-bis(sulfanyl)-4,5,5a,8,9a,10-hexahydro-1H-pyrano[3,2-g]pteridin-8-yl]methyl dihydrogen phosphate |
| molybdopterin | = H2Dtpp-mP |
| = {[(5aR,8R,9aR)-2-amino-4-oxo-6,7-bis(sulfanyl-κS)-1,5,5a,8,9a,10-hexahydro-4H-pyrano[3,2-g]pteridin-8-yl]methyl dihydrogenato(2-) phosphate}(dioxo)molybdate(2-) |
| monacolin J acid | = (3R,5R)-7-[(1S,2S,6R,8S,8aR)-8-hydroxy-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate |
| monacolin J acid | = (3R,5R)-7-[(1S,2S,6R,8S,8aR)-8-hydroxy-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid |
| monacolin L acid | = (3R,5R)-7-[(1S,2S,6R,8aR)-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate |
| monacolin L acid | = (3R,5R)-7-[(1S,2S,6R,8aR)-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid |
| monoanhydrobacterioruberin | = 2-(3-hydroxy-3-methylbutyl)-2′-(3-methylbut-2-enyl)-3,4,3′,4′-tetradehydro-1,2,1′,2′-tetrahydro-ψ,ψ-carotene-1,1′-diol |
| monoglucosyl-enterobactin | = N-(2,3-dihydroxybenzoyl)-O-[N-(2,3-dihydroxybenzoyl)-O-[N-(5-β-D-glucopyranosyl-2,3-dihydroxybenzoyl)-L-seryl]-L-seryl]-L-serine-3→1(3)-lactone |
| = mono-C-glucosyl-enterobactin |
| = salmochelin MGE |
| monoglucosyl-enterobactin | = N-(2,3-dihydroxybenzoyl)-O-[N-(2,3-dihydroxybenzoyl)-O-[N-(5-β-D-glucopyranosyl-2,3-dihydroxybenzoyl)-L-seryl]-L-seryl]-L-serine-[3→1(3)]-lactone |
| = mono-C-glucosyl-enterobactin |
| = salmochelin MGE |
| muramic acid | = 2-amino-3-O-[(R)-1-carboxyethyl]-2-deoxy-D-glucose |
| muscimol | = 5-(aminomethyl)-1,2-oxazol-3-ol |
| γ-muurolene | = (1S,4aS,8aR)-1-isopropyl-7-methyl-4-methylene-1,2,3,4,4a,5,6,8a-octahydronaphthalene |
| mycaminose | = 3,6-dideoxy-3-dimethylamino-glucopyranose |
| 3-O-α-mycarosylerythronolide B | = (3R,4S,5R,6R,7R,9R,11R,12S,13R,14R)-4-(2,6-dideoxy-3-C-methyl-α-L-ribo-hexopyranosyloxy)-14-ethyl-6,7,12-trihydroxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione |
| mycinamicin III | = [(2R,3R,4E,6E,9R,11S,12S,13S,14E)-2-ethyl-9,11,13-trimethyl-8,16-dioxo-12-{[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy}oxacyclohexadeca-4,6,14-trien-3-yl]methyl 6-deoxy-2-O-methyl-β-D-allopyranoside |
| mycinamicin IV | = [(2R,3R,4E,6E,9R,11S,12S,13S,14E)-2-ethyl-9,11,13-trimethyl-8,16-dioxo-12-{[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy}oxacyclohexadeca-4,6,14-trien-3-yl]methyl 6-deoxy-2,3-di-O-methyl-β-D-allopyranoside |
| mycinamicin VI | = [(2R,3R,4E,6E,9R,11S,12S,13S,14E)-2-ethyl-9,11,13-trimethyl-8,16-dioxo-12-{[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy}oxacyclohexadeca-4,6,14-trien-3-yl]methyl 6-deoxy-β-D-allopyranoside |
| mycobilin a | = 8,12-bis(2-carboxyethyl)-19-formyl-3,7,13,18-tetramethyl-3,17-divinylbiladiene-ab-1,15(21H)-dione |
| mycobilin b | = 8,12-bis(2-carboxyethyl)-19-formyl-2,7,13,17-tetramethyl-3,18-divinylbiladiene-ab-1,15(21H)-dione |
| mycocerosate | = 2,4,6-trimethyl- and 2,4,6,8-tetramethyl-2-alkanoic acids present in many pathogenic mycobacteria. The chiral centers bearing the methyl groups have an L (levorotatory) stereo configuration. |
| mycocerosic acid | = long-chain fatty acid with 3 or 4 methyl branches at positions 2,4,6 or 2,4,6,8, respectively. The carbon atoms bearing the methyl groups have the (R)-configuration. |
| mycocyclosin | = (1S,14S)-6,9-dihydroxy-15,17-diazatetracyclo[12.2.2.13,7.18,12]icosa-3(20),4,6,8(19),9,11-hexaene-16,18-dione |
| mycophenolate | = (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoate |
| mycothiol | = 1-O-[2-(N2-acetyl-L-cysteinamido)-2-deoxy-α-D-glucopyranosyl]-1D-myo-inositol |
| mycothiol | = 1-O-[2-(N2-acetyl-L-cysteinamido)-2-deoxy--D-glucopyranosyl]-1D-myo-inositol |
| mycothione | = oxidized (disulfide) form of mycothiol |
| myrcene | = 7-methyl-3-methyleneocta-1,6-diene |
| myricetin | = 3,3′,4′,5,5′,7-hexahydroxyflavone |
| 3′-NADP | = nicotinamide adenine dinucleotide 3′-phosphate |
| narcotine hemiacetal | = (3S)-6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-1,3-dihydroisobenzofuran-1-ol |
| naringenin | = 5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one |
| naringenin chalcone | = 2′,4,4′,6′-tetrahydroxychalcone |
| = 3-(4-hydroxyphemyl)-1-(2,4,6-trihydroxyphenyl)prop-2-en-1-one |
| naringenin chalcone | = 2′,4,4′,6′-tetrahydroxychalcone |
| = 3-(4-hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)prop-2-en-1-one |
| NDP | = nucleoside diphosphate |
| neamine | = (1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl 2,6-diamino-2,6-dideoxy-α-D-glucopyranoside |
| neamine | = (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-{[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy}oxane-3,4-diol |
| nebramycin 5′ | = (1S,2S,3R,4S,6R)-4,6-diamino-3-[(2,6-diamino-2,3,6-trideoxy-α-D-ribo-hexopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-6-O-carbamoyl-3-deoxy-α-D-glucopyranoside |
| NEDD | = Neural-precursor-cell Expressed Developmentally Down-regulated protein |
| neoagarobiose | = 3,6-anhydro-α-L-galactopyranosyl-(1→3)-D-galactose |
| ι-neocarrabiose | = 3,6-anhydro-2-O-sulfo-α-D-galactopyranosyl-(1→3)-4-O-sulfo-D-galactose |
| neopentalenolactone D | = (1S,4aR,6aS)-1,7,7-trimethyl-3-oxo-4,4a,6a,7,8,9-hexahydro-3H-pentaleno[6a,1-c]pyran-5-carboxylate |
| neopinone | = 3-methoxy-17-methyl-8,14-didehydro-4,5α-epoxymorphinan-6-one |
| neoverrucosan-5β-ol | = (1aS,3R,3aS,5aR,8S,8aR,8bR,8cS)-1a,3a,5a-trimethyl-8-(propan-2-yl)tetradecahydrocyclopenta[a]cyclopropa[h]naphthalen-3-ol |
| (R)-nephthenol | = 2-[(1R,3E,7E,11E)-4,8,12-trimethyltetradeca-3,7,11-trien-1-yl]propan-2-ol |
| nerol | = (2Z)-3,7-dimethylocta-2,6-dien-1-ol |
| neryl | = (2Z)-3,7-dimethylocta-2,6-dien-1-yl |
| nocamycin E | = (2R,3S,3aS,5R,6R,7S,9aS)-5-[(2R,3E,5E)-7-hydroxy-4-methyl-7-(2,4-dioxopyrroliden-3-ylidene)hepta-3,5-dien-2-yl]-2,6,9a-trimethyl-8-oxooctahydro-3a,7-epoxyfuro[3,2-b]oxocine-3-carboxylate |
| nocamycin I | = methyl (2R,3S,3aS,5R,6R,7S,9aS)-5-[(2R,3E,5E)-7-hydroxy-4-methyl-7-(2,4-dioxopyrroliden-3-ylidene)hepta-3,5-dien-2-yl]-2,6,9a-trimethyl-8-oxooctahydro-3a,7-epoxyfuro[3,2-b]oxocine-3-carboxylate |
| nocardicin A | = (2R)-2-amino-4-{4-[(1E)-{[(3S)-1-[(R)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl}(hydroxyimino)methyl]phenoxy}butanoic acid |
| nocardicin C | = (2R)-2-amino-4-{4-[(R)-amino({[(3S)-1-[(R)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl})methyl]phenoxy}butanoic acid |
| nogalaviketone | = methyl 5,7-dihydroxy-2-methyl-4,6,11-trioxo-3,4,6,11-tetrahydrotetracene-1-carboxylate |
| nogalonate | = [4,5-dihydroxy-9,10-dioxo-3-(3-oxobutanoyl)-9,10-dihydroanthracen-2-yl]acetate |
| nopaline | = N-{(1R)-1-carboxy-4-[(diaminomethylene)amino]butyl}-L-glutamate |
| norbelladine | = 4-({[2-(4-hydroxyphenyl)ethyl]amino}methyl)benzene-1,2-diol |
| norcoclaurine | = 6,7-dihydroxy-1-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline |
| noroxomaritidine | = 8-hydroxy-9-methoxy-4,4a-dihydro-3H,6H-5,10b-ethanophenanthridin-3-one |
| norsolorinate | = 2-hexanoyl-1,3,6,8-tetrahydroxy-9,10-anthraquinone |
| norspermine | = N,N′-bis(3-aminopropyl)-1,3-propanediamine |
| noscapine | = (3S)-6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-5-yl]isobenzofuran-1(3H)-one |
| novobiocic acid | = N-(2,7-dihydroxy-8-methyl-4-oxo-4H-chromen-3-yl)-4-hydroxy-3-(3-methylbut-2-en-1-yl)benzamide |
| novobiocic acid | = N-(2,7-dihydroxy-8-methyl-4-oxochromen-3-yl)-4-hydroxy-3-(3-methylbut-2-enyl) benzamide |
| obtusifoliol | = 4α,14α-dimethyl-5α-ergosta-8,24(28)-dien-3β-ol or 4α,14α-dimethyl-24-methylene-5α-cholesta-8-en-3β-ol |
| okenone | = 1′-methoxy-1′,2′-dihydro-χ,ψ-caroten-4′-one |
| oleoyl-CoA | = cis-octadec-9-enoyl-CoA |
| = (9Z)-octadec-9-enoyl-CoA |
| = 18:1 cis-9 |
| oleuropein | = methyl (2R,3E,4S)-4-{2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl}-3-ethylidene-2-(β-D-glucopyranosyloxy)-3,4-dihydro-2H-pyran-5-carboxylate |
| oleuropein aglycone | = methyl (2S,3E,4S)-4-{2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl}-3-ethylidene-2-hydroxy-3,4-dihydro-2H-pyran-5-carboxylate |
| α-onocerin | = 8,14-secogammacera-8(26),14(27)-diene-3β,21α-diol |
| oroxylin | = 5,7-dihydroxy-6-methoxyflavone |
| = 5,7-dihydroxy-6-methoxy-2-phenyl-4H-1-benzopyran-4-one |
| oryzalexin D | = ent-sandaracopimaradiene-3β,7α-diol |
| = (3R,4aR,4bS,7S,9S,10aS)-7-ethenyl-1,1,4a,7-tetramethyl-1,2,3,4,4a,4b,5,6,7,9,10,10a-dodecahydrophenanthren-2,9-diol |
| oryzalexin E | = ent-sandaracopimaradiene-3β,9α-diol |
| = (3R,4aR,4bS,7S,10aR)-7-ethenyl-1,1,4a,7-tetramethyl-1,2,3,4,4a,4b,5,6,7,9,10,10a-dodecahydrophenanthren-2,4b-diol |
| osthenol | = 7-hydroxy-8-prenyl-1-benzopyran-2-one |
| oxetane | = 1,3-propylene oxide |
| = 4-membered oxygen-containing ring |
| oxidized coenzyme F420 | = N-(N-{O-[5-(8-hydroxy-2,4-dioxo-2,3,4,10-tetrahydropyrimido[4,5-b]quinolin-10-yl)-5-deoxy-L-ribityl-1-phospho]-(S)-lactyl}-γ-L-glutamyl)-L-glutamate |
| oxirane | = ethylene oxide |
| = 3-membered oxygen-containing ring |
| 8-oxo-dGDP | = 8-oxo-7,8-dihydro-2′-deoxyguanosine 5′-diphosphate |
| 8-oxo-dGTP | = 2′-deoxy-7,8-dihydro-8-oxoguanosine 5′-triphosphate |
| 8-oxo-dGTP | = 8-oxo-7,8-dihydro-2′-deoxyguanosine 5′-triphosphate |
| 5′-oxoaverantin | = 1,3,6,8-tetrahydroxy-2-[(1S)-1-hydroxy-5-oxohexyl]anthracene-9,10-dione |
| p-tRNAHis | = 5′-phospho-ribonucleotide-[tRNAHis] |
| palatinose | = 6-O-α-D-glucopyranosyl-D-fructofuranose |
| pantoate | = 2,4-dihydroxy-3,3-dimethylbutanoate |
| α-parinarate | = (9Z,11E,13E,15Z)-octadeca-9,11,13,15-tetraenoate |
| paromamine | = (1R)-O4-(2-amino-2-deoxy-α-D-glucopyranosyl)-2-deoxy-streptamine |
| paromamine | = (1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl 2-amino-2-deoxy-α-D-glucopyranoside |
| 2,4,6/3,5-pentahydroxycyclohexanone | = (2R,3S,4s,5R,6S)-2,3,4,5,6-pentahydroxycyclohexanone |
| = scyllo-inosose |
| pentalenate | = (1R,3aR,5aS,6R,8aS)-6-hydroxy-1,7,7-trimethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene-4-carboxylate |
| pentalenene | = (1R,8aR)-1,4,7,7-tetramethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene |
| pentalenene | = (3aS,5aS,8aR)-1,4,7,7-tetramethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene |
| pentalenolactone | = (1R,4aR,6aR,7S,9aS)-7,8-dimethyl-2-oxo-4,4a,6a,7-tetrahydrospiro[oxirane-2,1-pentaleno[1,6a-c]pyran]-5-carboxylic acid |
| pentalenolactone D | = (1S,4aR,6aS,9aR)-1,8,8-trimethyl-2-oxo-1,2,4,4a,6a,7,8,9-octahydropentaleno[1,6a-c]pyran-5-carboxylate |
| pentalenolactone E | = (4aR,6aS,9aR)-8,8-dimethyl-1-methylene-2-oxo-1,2,4,4a,6a,7,8,9-octahydropentaleno[1,6a-c]pyran-5-carboxylate |
| pentalenolactone F | = (1′R,4′aR,6′aS,9′aR)-8′,8′-dimethyl-2′-oxo-4′,4′a,6′a,8′,9′-hexahydrospiro[oxirane-2,1′-pentaleno[1,6a-c]pyran]-5′-carboxylic acid |
| pentalenolactone F | = (1R,4aR,6aS,9aR)-8,8-dimethyl-2-oxo-4,4a,6a,8,9-hexahydrospiro[oxirane-2,1-pentaleno[1,6a-c]pyran]-5-carboxylic acid |
| perakine | = raucaffrine |
| = (17R,20α,21β)-1,2-didehydro-1-demethyl-17-(acetyloxy)-21-methyl-18-norajmalan-19-al |
| pGp-tRNAHis | = 5′-phospho-guanosine-ribonucleotide-[tRNAHis] |
| phaseolotoxin | = N5-[amino(sulfoamino)phosphoryl]-L-ornithyl-L-alanyl-L-arginine |
| phenolphthiocerol | = compound related to phthiocerol that contains a phenol group at the ω end of the molecule |
| phloretin | = 3-(4-hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)propan-1-one |
| phlorizin | = 3-(4-hydroxyphenyl)-1-[2-(β-D-glucopyranosyloxy)-4,6-dihydroxyphenyl]propan-1-one |
| phosphatidylserine | = 3-sn-phosphatidyl-L-serine |
| = 1,2-diacyl-sn-glycero-3-phospho-L-serine |
| (4-O-phospho-KDO)-lipid IVA | = 4-O-phospho-α-Kdo-(2→6)-lipid IVA |
| = (3-deoxy-4-O-phosphono-α-D-manno-oct-2-ulopyranosylonate)-(2→6)-2-deoxy-2-{[(3R)-3-hydroxytetradecanoyl]amino}-3-O-[(3R)-3-hydroxytetradecanoyl]-4-O-phosphono-β-D-glucopyranosyl-(1→6)-2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-{[(3R)-3-hydroxytetradecanoyl]amino}-1-O-phosphono-α-D-glucopyranose |
| phthiocerol | = linear carbohydrate molecule to which one methoxyl group, one methyl group, and two secondary hydroxyl groups are attached. |
| phthiocerols | = linear carbohydrates containing one methoxyl group, one methyl group, and two secondary hydroxyl groups that serve as a backbone for certain lipids and glycolipids found in many species of Mycobacteriaceae |
| phthiodiolone | = intermediate in phthiocerol biosynthesis, containing an oxo group where phthiocerols contain a methoxyl group |
| phylloquinol | = 2-methyl-3-phytyl-1,4-naphthoquinol |
| = vitamin K1 |
| phylloquinone | = vitamin K1 |
| = 2-methyl-3-phytyl-1,4-naphthoquinone |
| phytanate | = 3,7,11,15-tetramethylhexadecanoate |
| phytanol | = (7R,11R,15R)-3,7,11,15-tetramethylhexadecan-1-ol |
| phytanol | = 3,7,11,15-tetramethylhexadecan-1-ol |
| phytoceramide | = (4R)-4-hydroxysphinganine ceramide |
| = N-acyl-4-hydroxysphinganine |
| β-pinacene | = 4,8,12-trimethyl-1-(propan-2-yl)cyclotetradeca-1,3,7,11-tetraene |
| (+)-α-pinene | = (1R,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-2-ene |
| (+)-β-pinene | = (1R,5R)-6,6-dimethyl-2-methylenebicyclo[3.1.1]hept-2-ene |
| (-)-α-pinene | = (1S,5S)-2,6,6-trimethylbicyclo[3.1.1]hept-2-ene |
| (-)-β-pinene | = (1S,5S)-6,6-dimethyl-2-methylenebicyclo[3.1.1]hept-2-ene |
| (–)-pinoresinol | = (1R,3aS,4R,6aS)-4,4′-(tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl)bis(2-methoxyphenol) |
| (+)-pinoresinol | = (1S,3aR,4S,6aR)-4,4-(tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl)bis(2-methoxyphenol) |
| (+)-pisatin | = (6aR,12aR)-3-methoxy-6H-[1,3]dioxolo[5,6][1]benzofuro[3,2-c]chromen-6a(12aH)-ol |
| (–)-pluviatolide | = ((3R,4R)-4-(2H-1,3-benzodioxol-5-ylmethyl)-3-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one |
| (–)-pluviatolide | = (3R,4R)-4-(2H-1,3-benzodioxol-5-ylmethyl)-3-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one |
| polyacyltrehalose | = PAT |
| = 2-(long-chain-fatty acyl)-2′,3,4′,6-tetramycolipenoyl-trehalose |
| L-polyhomomethionine | = analogs of L-methionine that contain additional methylene groups in the side chain prior to the sulfur atom. |
| PqqA peptide | = pyrroloquinoline quinone biosynthesis protein A, a small peptide that provides the precursor for the biosynthesis of the cofactor pyrroloquinoline quinone |
| pre-sodorifen diphosphate | = [(2E)-3-methyl-5-[(1S,4R,5R)-1,2,3,4,5-pentamethylcyclopent-2-en-1-yl]pent-2-en-1-yl phosphonato]oxyphosphonate |
| prenyl | = 3-methylbut-2-en-1-yl |
| prenyl | = 3-methylbut-2-en-1-yl |
| = dimethylallyl |
| prenyl | = 3-methylbut-2-en-1-yl |
| = dimethylallyl (ambiguous) |
| 4-prenyl-L-abrine | = 4-(3-methylbut-2-enyl)-L-abrine |
| = 4-dimethylallyl-L-abrine (ambiguous) |
| prenylated FMNH2 | = 3,3,4,5-tetramethyl-7-[(2S,3S,4R)-2,3,4-trihydroxy-5-(phosphonatooxy)pentyl]-2,3-dihydro-1H,7H-naphtho[1,8-fg]pteridine-9,11(8H,10H)-dione |
| preQ0 | = 7-cyano-7-carbaguanine |
| = 7-cyano-7-deazaguanine |
| presqualene | = {(1R,2R,3R)-2-[(3E)-4,8-dimethylnona-3,7-dien-1-yl]-2-methyl-3-[(2E,6E)-2,6,10-trimethylundeca-1,5,9-trien-1-yl]cyclopropan-1-yl}methyl |
| (+)-(2S,3R,9R)-pristinol | = (1R,6R,9aS)-1,4,8,8-tetramethyl-2,3,5,6,7,8,9,9a-octahydro-1H-cyclopenta[8]annulen-6-ol |
| prosolanapyrone II | = 3-(hydroxymethyl)-4-methoxy-6-(1E,7E,9E)-undeca-1,7,9-trien-1-yl-2H-pyran-2-one |
| prosolanapyrone III | = 4-methoxy-2-oxo-6-(1E,7E,9E)-undeca-1,7,9-trien-1-yl-2H-pyran-3-carboxaldehyde |
| prostaglandin H2 | = (5Z,9α,11α,13E,15S)-9,11-epidioxy-15-hydroxy-prosta-5,13-dienoate |
| prostamide F2α | = (5Z,9α,11α,13E,15S)-9,11,15-trihydroxy-N-(2-hydroxyethyl)prosta-5,13-dien-1-amide |
| prostamide H2 | = (5Z)-N-(2-hydroxyethyl)-7-{(1R,4S,5R,6R)-6-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-2,3-dioxabicyclo[2.2.1]hept-5-yl}hept-5-enamide |
| (2S,3R,6S,9S)-(–)-protoillud-7-ene | = (2aS,4aS,7aS,7bR)-3,6,6,7b-tetramethyl-2,2a,4a,5,6,7,7a,7b-octahydro-1H-cyclobuta[e]indene |
| Δ6-protoilludene | = (4aS,7aS,7bR)-3,6,6,7b-tetramethyl-2,4,4a,5,6,7,7a,7b-octahydro-1H-cyclobuta[1,2-e]indene |
| protoviolaceinate | = 5-(5-hydroxy-1H-indol-3-yl)-3-(1H-indol-3-yl)-1H-pyrrole-2-carboxylate |
| PRPP | = 5-phospho-α-D-ribose 1-diphosphate |
| pseudaminic acid | = 5,7-bis(acetylamino)-3,5,7,9-tetradeoxy-L-glycero-α-L-manno-2-nonulopyranosonic acid |
| pseudaminic acid | = 5,7-diacetylamino-3,5,7,9-tetradeoxy-L-glycero-α-L-manno-2-nonulopyranosonic acid |
| pseudolaradiene | = (1RS,3aSR,8aRS)-3a,6-dimethyl-1-(6-methylhepta-2,5-dien-2-yl)-1,2,3,3a,4,7,8,8a-octahydrohydroazulene |
| Ψ | = pseudouridine |
| psilocybin | = 3-[2-(dimethylamino)ethyl]-1H-indol-4-yl phosphate |
| (+)-pterocarpan | = (6aR,11aR)-6a,11a-dihydro-6H-[1]benzofuran[3,2-c][1]benzopyran |
| pullulan | = linear polymer of (1→6)-linked maltotriose units |
| punicate | = (9Z,11E,13Z)-octadeca-9,11,13-trienoate |
| pyoluteorin | = 4,5-dichloro-1H-pyrrol-2-yl 2,6-dihydroxyphenyl |
| pyridoxamine | = 4-aminomethyl-3-hydroxy-5-hydroxymethyl-2-methylpyridine |
| 5-pyridoxate | = 3-hydroxy-4-hydroxymethyl-2-methylpyridine-5-carboxylate |
| 4-pyridoxate | = 3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxylate |
| pyrithiamine | = 1-(4-amino-2-methylpyrimid-5-ylmethyl)-3-(2-hydroxyethyl)-2-methylpyridinium bromide hydrobromide |
| L-pyrrolysine | = N6-{[(2R,3R)-3-methyl-3,4-dihydro-2H-pyrrol-2-yl]carbonyl}-L-lysine |
| questin | = 1,6-dihydroxy-8-methoxy-3-methyl-9,10-anthraquinone |
| questin | = 3,8-dihydroxy-1-methoxy-6-methylanthracene-9,10-dione |
| queuine | = base Q |
| = 2-amino-5-({[(1S,4S,5R)-4,5-dihydroxycyclopent-2-en-1-yl]amino}methyl)-1,7-dihydropyrrolo[3,2-e]pyrimidin-4-one |
| quinate | = (1R,3R,4R,5R)-1,3,4,5-tetrahydroxycyclohexanecarboxylic acid and is a cyclitol carboxylate |
| raffinose | = β-D-fructofuranosyl α-D-galactopyranosyl-(1→6)-α-D-glucopyranoside |
| raucaffrinoline | = (17R,20α,21β)-1,2-didehydro-1-demethyl-19-hydroxy-21-methyl-18-norajmalan-17-yl acetate |
| RBR | = RING between RING |
| RCR | = RING-Cys-Relay |
| Reactive Blue 5 | = 1-amino-4-{[3-({4-chloro-6-[(3-sulfophenyl)amino]-1,3,5-triazin-2-yl}amino)-4-sulfophenyl]amino}-9,10-dihydro-9,10-dioxoanthracene-2-sulfonic acid |
| red chlorophyll catabolite | = RCC |
| = (7S,8S,101R)-8-(2-carboxyethyl)-17-ethyl-19-formyl-101-(methoxycarbonyl)-3,7,13,18-tetramethyl-2-vinyl-8,23-dihydro-7H-10,12-ethanobiladiene-ab-1,102(21H)-dione |
| red chlorophyll catabolite | = RCC |
| = (7S,8S,101R)-8-(2-carboxyethyl)-8,23-dihydro-17-ethyl-19-formyl-101-(methoxycarbonyl)-3,7,13,18-tetramethyl-2-vinyl-7H-10,12-ethanobiladiene-ab-1,102(21H)-dione |
| reduced (S)-usnate | = reduced (-)-usnate |
| = (6R)-2-acetyl-6-(3-acetyl-2,4,6-trihydroxy-5-methylphenyl)-3-hydroxy-6-methyl-2,4-cyclohexadien-1-one |
| (R)-reticuline | = (1R)-1-[(3-hydroxy-4-methoxyphenyl)methyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ol |
| (S)-reticuline | = (1S)-1-(3-hydroxy-4-methoxybenzyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ol |
| (S)-reticuline | = (1S)-1-[(3-hydroxy-4-methoxyphenyl)methyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ol |
| reticuline | = 1-(3-hydroxy-4-methoxybenzyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ol |
| rhabduscin | = N-[(2S,3S,4R,5S,6R)-4,5-dihydroxy-6-{4-[(E)-2-isocyanoethenyl]phenoxy}-2-methyloxan-3-yl]acetamide |
| rhizobitoxine | = (2S,3E)-2-amino-4-[(2R)-2-amino-3-hydroxypropoxy]but-3-enoate |
| ε-rhodomycinone | = methyl (1R,2R,4S)-2-ethyl-2,4,5,7,12-pentahydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate |
| ribostamycin | = (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-{[(1R,2R,3S,4R,6S)-4,6-diamino-2-{[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-hydroxycyclohexyl]oxy}oxane-3,4-diol |
| rifampicin | = (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{[(E)-(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca-1,11,13-trienoimino)nathpho[2,1-b]furan-21-yl acetate |
| rifampicin | = rifampin |
| = 3-[(4-methylpiperazin-1-yl)iminomethyl]rifamycin |
| rifamycin SV | = (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9, 19,21,25(29),26-octaen-13-yl acetate |
| RING | = Really Interesting New Gene |
| rosmarinate | = (2R)-3-(3,4-dihydroxyphenyl)-2-{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}propanoate |
| rubredoxin | = iron-containing protein found in sulfur-metabolizing bacteria and archaea, participating in electron transfer |
| rutinose | = 6-O-α-L-rhamnopyranosyl-D-glucose |
| (+)-sabinene | = (+)-thuj-4(10)-ene |
| = (1R,5R)-1-isopropyl-4-methylenebicyclo[3.1.0]hexane |
| (-)-sabinene | = (1S,5S)-1-isopropyl-4-methylenebicyclo[3.1.0]hexane |
| salmochelin S1 | = O-3-[N-(2,3-dihydroxybenzoyl)-L-seryl]-N-(C-5-deoxy-β-D-glucosyl-2,3-dihydroxybenzoyl)-L-serine |
| salmochelin S2 | = O-3-{O-3-[N-(2,3-dihydroxybenzoyl)-C-5-deoxy-β-D-glucosyl-L-seryl]-N-(2,3-dihydroxybenzoyl)-C-5-deoxy-β-D-glucosyl-L-seryl}-N-(2,3-dihydroxybenzoyl)-L-serine |
| salmochelin SX | = N-(C-5-deoxy-β-D-glucosyl-2,3-dihydroxybenzoyl)-L-serine |
| salvianin | = pelargonidin 3-O-(6-caffeoyl-β-D-glucoside) 5-O-(4,6-di-O-malonyl-β-D-glucoside) |
| salviol | = abieta-8,11,13-triene-2α,12-diol |
| SAMP | = small archaeal modifier protein |
| SAMP | = small archaeal modifier protein |
| = ubiquitin-like small archaeal modifier protein |
| ent-sandaracopimaradien-3β-ol | = (3R,4aR,4bR,7S,10aS)-7-ethenyl-1,1,4a,7-tetramethyl-1,2,3,4,4a,4b,5,6,7,9,10,10a-dodecahydrophenanthren-2-ol |
| ent-sandaracopimaradiene | = ent-13α-pimara-8(14),15-diene |
| = (4aR,4bR,7S,10aR)-7-ethenyl-1,1,4a,7-tetramethyl-1,2,3,4,4a,4b,5,6,7,9,10,10a-dodecahydrophenanthrene |
| sanguinarine | = 13-methyl-2H,10H-[1,3]dioxolo[4,5-i][1,3]dioxolo[4′,5′:4,5]benzo[1,2-c]phenanthridinium |
| scopolamine | = hyoscine |
| = (1R,2R,4S,5S,7s)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate |
| (S)-scoulerine | = (13aS)-3,10-dimethoxy-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline-2,9-diol |
| scutellarein | = 4,5,6,7-tetrahydroxyflavone-7-O-β-D-glucoronate |
| = 5,6,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one |
| secalciferol | = (24R),25-dihydroxyvitamin D3 |
| = (3S,5Z,7E,24R)-9,10-secocholesta-5,7,10-triene-3,24,25-triol |
| secalciferol | = (24R)-24,25-dihydroxycalciol |
| = 24R,25-dihydroxyvitamin D3 |
| = (3R,5Z,7E,24R)-9,10-seco-5,7,10(19)-cholestatriene-3,24,25-triol |
| 4,5-secobiotin | = 6-[(4R,5R)-2-oxo-5-(sulfanylmethyl)imidazolidin-4-yl]hexanoate |
| = 9-mercaptodethiobiotin |
| α-selinene | = (2R,4aR,8aS)-4,8a-dimethyl-2-(prop-1-en-2-yl)-1,2,3,4,4a,5,6,8a-octahydronaphthalene |
| 7-epi-α-selinene | = (2S,4aR,8aR)-4a,8-dimethyl-2-(prop-1-en-2-yl)-1,2,3,4,4a,5,6,8a-octahydronaphthalene |
| (+)-δ-selinene | = (4aR)-1,4a-dimethyl-7-(propan-2-yl)-2,3,4,4a,5,6-hexahydronaphthalene |
| β-selinene | = (4aR,7R,8aS)-4a-methyl-1-methylidene-7-(prop-1-en-2-yl)decahydronaphthalene |
| 5-epi-α-selinene | = 5β-eudesma-3,11-diene |
| = (2R,4aR,8aS)-1,2,3,4,4a,5,6,8a-octahydro-4a,8-dimethyl-2-(prop-1-en-2-yl)naphthalene |
| sepiapterin | = 2-amino-6-lactoyl-7,8-dihydropteridin-4(3H)-one |
| (+)-sesamin | = 5,5′-[(1S,3aR,4S,6aR)-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl]bis(1,3-benzodioxole) |
| sesterfisherol | = (3R,3aS,6S,6aR,7aR,10R,10aS,11aR)-3,6,7a,12-tetramethyl-10-(propan-2-yl)-2,3,3a,4,5,6,6a,7,7a,8,9,10,10a,11-tetradecahydrocyclopenta[4,5]cycloocta[f]inden-11a(1H)-ol |
| sinapate | = (2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate |
| sinapate | = 4-hydroxy-3,5-dimethoxycinnamate |
| sinapoyl | = 4-hydroxy-3,5-dimethoxycinnamoyl |
| sodorifen | = (1S,2R,8S)-1,2,4,5,6,7,8-Heptamethyl-3-methylenebicyclo[3.2.1]oct-6-ene |
| sodorifen | = (1S,2S,4R,5S,8s)-1,2,4,5,6,7,8-heptamethyl-3-methylenebicyclo[3.2.1]oct-6-ene |
| solabiose | = β-D-glucopyranosyl-(1→3)-D-galactose |
| (–)-solanapyrone A | = 4-methoxy-6-((1R,2S,4aR,8aR)-2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl)-2-oxo-2H-pyran-3-carboxaldehyde |
| sophoraflavanone B | = (–)-(2S)-8-prenylnaringenin |
| = (–)-(2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-4H-chromen-4-one |
| sophoraflavanone B | = (–)-(2S)-8-prenylnaringenin |
| = (–)-(2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-en-1-yl)-2,3-dihydrochromen-4-one |
| sophoraflavanone G | = (2S)-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2R)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-2,3-dihydro-4H-chromen-4-one |
| sophorose | = β-D-glucopyranosyl-(1→2)-D-glucopyranose |
| sordaricin | = (1R,3aR,4S,4aR,7R,7aR,8aR)-4-formyl-8a-(hydroxymethyl)-7-methyl-3-(propan-2-yl)-1,3a,4,4a,5,6,7,7a,8,8-decahydro-1,4-methanocyclopenta[f]indene-3a-carboxylic acid |
| soyasaponin III | = 3β-(2-O-β-D-galactopyranosyl-β-D-glucopyranosyloxyuronic acid)olean-12-ene-22β,24-diol |
| spectinabilin | = 2-methoxy-3,5-dimethyl-6-[(2R,4Z)-4-[(2E,4E,6E)-2,4,6-trimethyl-7-(4-nitrophenyl)hepta-2,4,6-trien-1-ylidene]oxolan-2-yl]pyran-4-one |
| spectinabilin | = neoaureothin |
| = 2-methoxy-3,5-dimethyl-6-[(2R,4Z)-4-[(2E,4E,6E)-2,4,6-trimethyl-7-(4-nitrophenyl)hepta-2,4,6-trien-1-ylidene]oxolan-2-yl]-4H-pyran-4-one |
| spermine | = N,N′-bis(3-aminopropyl)butane-1,4-diamine |
| spheroidene | = 3,4-didehydro-1-methoxy-1,2,7′,8′-tetrahydro-ψ,ψ-carotene |
| sphingoid | = sphinganine, i.e. D-erythro-2-aminooctadecane-1,3-diol, and its homologues and stereoisomers (see also Lip-1.4) |
| sphingoid base | = amino alcohol, composed predominantly of 18 carbon atoms, characterised by the presence of a hydroxyl group at C-1 (and often also at C-3), and an amine group at C-2 |
| sphingoid base | = amino alcohol, composed predominantly of 18 carbon atoms, characterized by the presence of a hydroxyl group at C-1 (and often also at C-3), and an amine group at C-2. |
| (–)-spiroviolene | = (2R,3a′S,3b′R,5R,6a′R)-2,4′,4′,5,6a′-pentamethyl-2′,3′,3a′,3b′,4′,5′,6′,6a′-octahydrospiro[cyclopentane-1,1′-cyclopenta[a]pentalene] |
| sporulenol | = (1R,2R,4aS,4bR,6aS,10aS,10bR,12aS)-2,4b,7,7,10a,12a-hexamethyl-1-[(3R)-3-(4-methylcyclohexa-1,4-dien-1-yl)butyl]octadecahydrochrysen-2-ol |
| β-staphylobilin | = 10-oxo-β-bilirubin |
| = 3,7-bis(2-carboxyethyl)-2,8,13,18-tetramethyl-12,17-divinylbiladiene-ac-1,10,19(21H,24H)-trione |
| δ-staphylobilin | = 10-oxo-δ-bilirubin |
| = 3,7-bis(2-carboxyethyl)-2,8,12,17-tetramethyl-13,18-divinylbiladiene-ac-1,10,19(21H,24H)-trione |
| staphyloferrin B | = 5-[(2-{[(3S)-5-{[(2S)-2-amino-2-carboxyethyl]amino}-3-carboxy-3-hydroxy-5-oxopentanoyl]amino}ethyl)amino]-2,5-dioxopentanoate |
| staphylopine | = (2S)-4-{[(1R)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]amino}-2-[(1-carboxyethyl)amino]butanoate |
| staphylopine | = N-[(3S)-3-{[(1S)-1-carboxyethyl]amino}-3-carboxypropyl]-D-histidine |
| stearidonate | = (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate |
| stellata-2,6,19-triene | = (3S,3aR,5aR,7E,11E,14aR,14bR)-5a,8,12,14b-tetramethyl-3-(prop-1-en-2-yl)-1,2,3,3a,4,5,5a,6,9,10,13,14,14a,14b-tetradecahydrocycloundeca[e]indene |
| sterigmatocystin | = 3a,12c-dihydro-8-hydroxy-6-methoxyfuro[3′,2′:4,5]furo[2,3-c]xanthen-7-one |
| stipitatate | = 3,6-dihydroxy-5-oxocyclohepta-1,3,6-triene-1-carboxylate |
| sugiol | = 12-hydroxyabieta-8,11,13-trien-7-one |
| 4-sulfomuconolactone | = 4-carboxymethylen-4-sulfobut-2-en-olide |
| = 2-(5-oxo-2-sulfo-2,5-dihydrofuran-2-yl)acetic acid |
| (R)-synephrine | = D-(-)-synephrine |
| = 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol |
| T | = ribothymidine |
| = 5-methyluridine |
| (+)-T-muurolol | = (1R,4R,4aS,8aR)-1,6-dimethyl-4-(propan-2-yl)-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-ol |
| tauropine | = N2-(D-1-carboxyethyl)-2-aminoethanesulfonate |
| taxusin | = taxa-4(20),11-diene-5α,9α,10β,13α-tetrayl tetraacetate |
| (S)-tembetarine | = (1S)-1-(3-hydroxy-4-methoxybenzyl)-6-methoxy-2,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-7-ol |
| tenuazonic acid | = (5S)-3-acetyl-5-[(2S)-butan-2-yl]-4-hydroxy-1,5-dihydro-2H-pyrrol-2-one |
| terpentedienyl diphosphate | = (2E)-3-methyl-5-[(1R,2R,4aS,8aS)-1,2,4a,5-tetramethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl]pent-2-en-1-yl diphosphate |
| testolate | = 13-hydroxy-3-oxo-13,17-secoandrost-4-en-17-oate |
| tetracenomycin A2 | = methyl 10,12-dihydroxy-3,8-dimethoxy-1-methyl-6,11-dioxo-6,11-dihydrotetracene-2-carboxylate |
| tetracenomycin C | = methyl (6aR,7S,10aR)-6a,7,10a,12-tetrahydroxy-3,8-dimethoxy-1-methyl-6,10,11-trioxo-6,6a,7,10,10a,11-hexahydrotetracene-2-carboxylate |
| tetracenomycin D3 | = 3,8,10,12-tetrahydroxy-1-methyl-6,11-dioxo-6,11-dihydrotetracene-2-carboxylate |
| = 6,11-dihydro-3,8,10,12-tetrahydroxy-1-methyl-6,11-dioxonaphthacene-2-carboxylate |
| tetracenomycin F1 | = 3,8,10,12-tetrahydroxy-1-methyl-11-oxo-6,11-dihydro-2-tetracenecarboxylate |
| = 6,11-dihydro-3,8,10,12-tetrahydroxy-1-methyl-11-oxonaphthacene-2-carboxylate |
| tetracenomycin F2 | = (3E)-4-(3-acetyl-4,5,7-trihydroxy-10-oxo-9,10-dihydroanthracen-2-yl)-3-hydroxybut-3-enoate |
| tetracenomycin F2 | = 4-(3-acetyl-4,5,7,10-tetrahydroxyanthracen-2-yl)-3-oxobutanoic acid |
| tetrahydrobiopterin | = 5,6,7,8-tetrahydrobiopterin |
| = 2-amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydropteridin-4(3H)-one |
| Δ9-tetrahydrocannabinolate | = Δ9-THCA |
| = (6aR,10aR)-1-hydroxy-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromene-2-carboxylate |
| tetrahydromethanopterin | = 1-(4-{(1R)-1-[(6S,7S)-2-amino-7-methyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl]ethylamino}phenyl)-1-deoxy-5-O-{5-O-[(1S)-1,3-dicarboxypropylphosphonato]-α-D-ribofuranosyl}-D-ribitol |
| thetin | = sulfobetaine |
| = dimethylsulfonioacetate |
| thiamine diphosphate | = 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-diphosphoethyl)-4-methyl-1,3-thiazolium |
| thiomarinols | = natural products that combine monic acid and the compact holothin core of the dithiolopyrrolones. |
| L-thyroxine | = O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine |
| tobramycin | = (1S,2S,3R,4S,6R)-4,6-diamino-3-(2,6-diamino-2,3,6-trideoxy-α-D-ribo-hexopyranosyloxy)-2-hydroxycyclohexyl 3-amino-3-deoxy-α-D-glucopyranoside |
| toxoflavin | = 1,6-dimethylpyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione |
| triglucosyl-enterobactin | = N-(5-β-D-glucopyranosyl-2,3-dihydroxybenzoyl)-O-[N-(5-β-D-glucopyranosyl-2,3-dihydroxybenzoyl)-O-[N-(5-β-D-glucopyranosyl-2,3-dihydroxybenzoyl)-L-seryl]-L-seryl]-L-serine-(3→1(3))-lactone |
| = tri-C-glucosyl-enterobactin |
| = salmochelin TGE |
| trioxilin A3 | = (5Z,9E,14Z)-(8ξ,11ξ,12S)-8,11,12-trihydroxyicosa-5,9,14-trienoate |
| tropine | = tropan-3α-ol |
| = 3α-hydroxytropane |
| tropine | = tropan-3β-ol |
| = 3β-hydroxytropane |
| tryprostatin A | = (3S,8aS)-3-{[6-methoxy-2-(3-methylbut-2-en-1-yl)-1H-indol-3-yl]methyl}hexahydropyrrolo[1,2-a]pyrazine-1,4-dione |
| tryprostatin B | = (3S,8aS)-3-{[2-(3-methylbut-2-en-1-yl)-1H-indol-3-yl]methyl}hexahydropyrrolo[1,2-a]pyrazine-1,4-dione |
| tsukubadiene | = (1S,3aS,5Z,7aS,10aR,11Z)-1,5,8,8,10a-pentamethyl-2,3,3a,4,7,7a,8,9,10,10a-decahydro-1H-dicyclopenta[a,d][9]annulene |
| TTQ | = tryptophan tryptophylquinone |
| 6-tuliposide B | = 6-O-[(3S)-3,4-dihydroxy-2-methylenebutanoyl]-D-glucose |
| tylonolide | = 2-[(4R,5S,6S,7R,9R,11E,13E,15R,16R)-16-ethyl-4,6-dihydroxy-15-(hydroxymethyl)-5,9,13-trimethyl-2,10-dioxooxacyclohexadeca-11,13-dien-7-yl]acetaldehyde |
| UDP | = uridine diphosphate |
| UMP | = uridine monophosphate |
| valienol | = (1S,2S,3S,4R)-5-(hydroxymethyl)cyclohex-5-ene-1,2,3,4-tetrol |
| 5-epi-valiolone | = (2R,3S,4S,5R)-2,3,4,5-tetrahydroxy-5-(hydroxymethyl)cyclohexanone |
| 2-epi-valiolone | = (2S,3S,4S,5S)-2,3,4,5-tetrahydroxy-5-(hydroxymethyl)cyclohexan-1-one |
| verruculogen | = (5R,10S,10aR,14aS,15bS)-10,10a-dihydroxy-6-methoxy-2,2-dimethyl-5-(2-methylprop-1-en-1-yl)-1,10,10a,14,14a,15b-hexahydro-12H-3,4-dioxa-5a,11a,15a-triazacycloocta[1,2,3-lm]indeno[5,6-b]fluorene-11,15(2H,13H)-dione |
| versicolorin B | = (3aR,12bS)-8,10,12-trihydroxy-1,2,3a,12b-tetrahydroanthra[2,3-b]furo[3,2-d]furan-6,11-dione |
| versicolorone | = 1,3,6,8-tetrahydroxy-2-[(2S)-1-hydroxy-5-oxohexan-2-yl]anthracene-5,10-dione |
| versiconal | = (2S,3S)-2,4,6,8-tetrahydroxy-3-(2-hydroxyethyl)anthra[2,3-b]furan-5,10-dione |
| versiconol | = 1,3,6,8-tetrahydroxy-3-[(2S)-1,4-dihydroxybutan-2-yl]anthracene-5,10-dione |
| versiconol acetate | = (3S)-4-hydroxy-3-[1,3,6,8-tetrahydroxy-9,10-dioxo-9,10-dihydroanthracen-2-yl]butyl acetate |
| vicianose | = 6-O-(α-L-arabinopyranosyl)-D-glucose |
| violacein | = (3E)-3-[5-(5-hydroxy-1H-indol-3-yl)-2-oxo-1,2-dihydro-3H-pyrrol-3-ylidene]-1,3-dihydro-2H-indol-2-one |
| wogonin | = 5,7-dihydroxy-8-methoxyflavone |
| = 5,7-dihydroxy-8-methoxy-2-phenyl-4H-chromen-4-one |
| wybutosine | = yW |
| = 7-{(3S)-3-(methoxycarbonyl)-3-(methoxycarbonylamino)propyl}-4,5-dimethyl-3-(β-D-ribofuranosyl)-3,4-dihydro-9H-imidazo[1,2-a]purin-9-one |
| wybutosine | = yW |
| = 7-{(3S)-4-methoxy-3-[(methoxycarbonyl)amino]-4-oxobutyl}-4,5-dimethyl-3-(β-D-ribofuranosyl)-3,4-dihydro-9H-imidazo[1,2-a]purin-9-one |
| xanthohumol | = 2′,4,4′-trihydroxy-6′-methoxy-3-prenylchalcone |
| = (2E)-1-[2,4-dihydroxy-6-methoxy-3-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one |
| XMP | = xanthosine 5′-phosphate |
| (–)-yaetin | = (3R,4R)-4-(2H-1,3-benzodioxol-5-ylmethyl)-3-[(3,4,5-trimethoxyphenyl)methyl]oxolan-2-one |
| (–)-yatein | = (3R,4R)-4-(1,3-benzodioxol-5-ylmethyl)-3-(3,4,5-trimethoxybenzyl)dihydrofuran-2(3H)-one |
| zealexin A1 | = (4S)-4-(5,5-dimethylcyclohex-1-en-1-yl)cyclohex-1-ene-1-carboxylate |
|
